                         Date Authorized
        Proprietary Name       Dosage Form                  Strength                NDA Applicant Name                 Generic
                                                                                                                 Entered the Market
1      ACCOLATE               Tablets           10 mg                             AstraZeneca                  11/19/2010
                                                                                  Pharmaceuticals
2      ACCOLATE               Tablets           20 mg                             AstraZeneca                  11/19/2010
                                                                                  Pharmaceuticals
3      ACCURETIC              Tablets           10 mg/12.5 mg                     Pfizer Pharmaceuticals       02/06/2006
                                                                                  Ltd.
4      ACCURETIC              Tablets           20 mg/12.5 mg                     Pfizer Pharmaceuticals       02/06/2006
                                                                                  Ltd.
5      ACCURETIC              Tablets           20 mg/25 mg                       Pfizer Pharmaceuticals       02/06/2006
                                                                                  Ltd.
                                                                                           Date Authorized
     Proprietary Name    Dosage Form              Strength     NDA Applicant Name                Generic
                                                                                         Entered the Market
6    ACEPHEN            Suppositories   120 mg                G & W Laboratories, Inc. Prior to 1/1/1999
7    ACETADOTE          Injection       6g/30mL (200 mg/mL)   Cumberland               1/7/2013
                                                              Pharmaceuticals, Inc.
8    ACTIGALL           Capsules        300 mg                Allergan Sales, LLC      08/13/2003
9    ACTIQ              Lozenge         200 mcg               Cephalon, Inc.           09/26/2006
10   ACTIQ              Lozenge         400 mcg               Cephalon, Inc.           09/26/2006
11   ACTIQ              Lozenge         600 mcg               Cephalon, Inc.           09/26/2006
12   ACTIQ              Lozenge         800 mcg               Cephalon, Inc.           09/26/2006
13   ACTIQ              Lozenge         1200 mcg              Cephalon, Inc.           09/26/2006
14   ACTIQ              Lozenge         1600 mcg              Cephalon, Inc.           09/26/2006
15   ACTIVELLA          Tablets         1 mg / 0.5 mg         Amneal Pharmaceuticals 2014 - 2015
16   ACTIVELLA          Tablets         0.5 mg / 0.1 mg       Amneal Pharmaceuticals 2014 - 2015
17   ACTONEL            Tablets         150 mg                Warner Chilcott Company 06/2014
                                                              LLC
18   ACTOPLUS-MET       Tablets         15 mg/850 mg          Takeda Pharmaceuticals 08/2013 - 07/2014
                                                              USA
19   ACTOPLUS-MET       Tablets         15 mg/500 mg          Takeda Pharmaceuticals Unknown
                                                              USA
20   ACTOS              Tablets         30 mg                 Takeda Pharmaceuticals 08/17/2012
                                                              USA
21   ACTOS              Tablets         15 mg                 Takeda Pharmaceuticals 08/17/2012
                                                              USA
22   ACTOS              Tablets         45 mg                 Takeda Pharmaceuticals 08/17/2012
                                                              USA
                                                                                          Date Authorized
     Proprietary Name    Dosage Form              Strength    NDA Applicant Name              Generic
                                                                                        Entered the Market
23   ACULAR LS          Ophthalmic        0.4%               Allergan, Inc.           11/11/2013
                        Solution
24   ADALAT CC          Extended-         30 mg              Alvogen Group Holdings   04/21/1993
                        release Tablets                      LLC
25   ADALAT CC          Extended-         60 mg              Alvogen Group Holdings   04/21/1993
                        release Tablets                      LLC
26   ADALAT CC          Extended-         90 mg              Alvogen Group Holdings   04/21/1993
                        release Tablets                      LLC
27   ADDERALL XR        Extended-         25 mg              Shire Development LLC    04/02/2009
                        release
                        Capsules
28   ADDERALL XR        Extended-         15 mg              Shire Development, LLC   10/2016 - 10/2017
                        release
                        Capsules
29   ADDERALL XR        Extended-         20 mg              Shire Development LLC    04/02/2009
                        release
                        Capsules
30   ADDERALL XR        Extended-         5 mg               Shire Development LLC    04/02/2009
                        release
                        Capsules
31   ADDERALL XR        Extended-         30 mg              Shire Development LLC    04/02/2009
                        release
                        Capsules
32   ADDERALL XR        Extended-         10 mg              Shire Development LLC    04/02/2009
                        release
                        Capsules
                                                                                           Date Authorized
     Proprietary Name     Dosage Form             Strength    NDA Applicant Name               Generic
                                                                                         Entered the Market
33   ADDERALL XR       Extended-        15 mg                Shire Development LLC     04/02/2009
                       release
                       Capsules
34   ADDERALL XR       Extended-        5 mg                 Shire Development LLC     10/2016 - 10/2017
                       release
                       Capsules
35   ADDERALL XR       Extended-        25 mg                Shire Development, LLC    10/2016 - 10/2017
                       release
                       Capsules
36   ADDERALL XR       Extended-        30 mg                Shire Development, LLC    10/2016 - 10/2017
                       release
                       Capsules
37   ADDERALL XR       Extended-        20 mg                Shire Development, LLC    10/2016 - 10/2017
                       release
                       Capsules
38   ADDERALL XR       Extended-        10 mg                Shire Development, LLC    10/2016 - 10/2017
                       release
                       Capsules
39   ADRENACLICK       Injection        0.15 mg              Amedra                    04/01/2010
40   ADRENACLICK       Injection        0.3 mg               Amedra                    04/01/2010
41   AIRDUO RESPICLICK Inhalation       232 mcg / 14 mcg     Teva Branded              04/2017
                       Powder                                Pharmaceutical Products
                                                             R&D Inc.
42   AIRDUO RESPICLICK   Inhalation     55 mcg / 14 mcg      Teva Branded              04/2017
                         Powder                              Pharmaceutical Products
                                                             R&D Inc.
                                                                                              Date Authorized
     Proprietary Name     Dosage Form                Strength    NDA Applicant Name               Generic
                                                                                            Entered the Market
43   AIRDUO RESPICLICK   Inhalation      113 mcg / 14 mcg       Teva Branded              04/2017
                         Powder                                 Pharmaceutical Products
                                                                R&D Inc.
44   ALDACTAZIDE       Tablets           25 mg/25 mg            G.D. Searle LLC           10/06/2003
45   ALDACTONE         Tablets           25 mg                  G.D. Searle LLC           6/18/2003
46   ALDACTONE         Tablets           50 mg                  G.D. Searle LLC           6/18/2003
47   ALDACTONE         Tablets           100 mg                 G.D. Searle LLC           6/18/2003
48   ALLEGRA           Tablets           30 mg                  Sanofi Aventis US LLC     02/2005 - 02/2006
49   ALLEGRA           Tablets           60 mg                  Sanofi Aventis US LLC     02/2005 - 02/2006
50   ALLEGRA           Tablets           180 mg                 Sanofi Aventis US LLC     02/2005 - 02/2006
51   ALLEGRA-D 12 HOUR Extended-         60 mg/120 mg           Sanofi Aventis US LLC     12/2004 - 12/2005
                       release Tablets
52   AMARYL            Tablets           1 mg                   Sanofi Aventis US LLC     11/2004 - 11/2005
53   AMARYL            Tablets           2 mg                   Sanofi Aventis US LLC     11/2004 - 11/2005
54   AMARYL            Tablets           4 mg                   Sanofi Aventis US LLC     11/2004 - 11/2005
55   AMBIEN            Tablets           5 mg                   Sanofi Aventis US LLC     12/2006 - 12/2007
56   AMBIEN            Tablets           10 mg                  Sanofi Aventis US LLC     12/2006 - 12/2007
57   AMBIEN CR         Extended-         12.5 mg                Sanofi Aventis U.S. LLC   12/2010
                       release Tablets
58   AMBIEN CR         Extended-         6.25 mg                Sanofi Aventis U.S. LLC   10/2010
                       release Tablets
59   AMICAR            Tablets           1000 mg                Clover Pharmaceuticals  06/01/2012
                                                                Corporation
60   AMMONUL             Injection       10% / 10%              Medicis Pharmaceutical  03/2017
                                                                Corp., Division of VPNA
                                                                                             Date Authorized
     Proprietary Name    Dosage Form               Strength     NDA Applicant Name               Generic
                                                                                           Entered the Market
61   AMOXIL             Powder for Oral   400 mg/5 mL when    Dr. Reddy's Laboratories   04/15/1999
                        Suspension        reconstituted       Inc.
62   AMOXIL             Powder for Oral   200 mg/5 mL when    Dr. Reddy's Laboratories   04/15/1999
                        Suspension        reconstituted       Inc.
63   AMOXIL             Tablets           500 mg              Dr. Reddy's Laboratories   07/10/1978
                                                              Inc.
64   AMOXIL             Tablets           875 mg              Dr. Reddy's Laboratories   07/10/1978
                                                              Inc.
65   ANAFRANIL          Capsules          25 mg               Mallinckrodt               07/2015
66   ANAFRANIL          Capsules          50 mg               Mallinckrodt               07/2015
67   ANAFRANIL          Capsules          75 mg               Mallinckrodt               07/2015
68   ANCOBAN            Capsules          250 mg              Valeant Pharmaceuticals    07/2017
                                                              North America LLC
69   ANCOBAN            Capsules          500 mg              Valeant Pharmaceuticals    01/17/2012
                                                              North America LLC
70   ANGIOMAX           Injection         250 mg              The Medicines Company      10/2015
71   ANTARA             Capsules          130 mg              Lupin Atlantis Holdings,   02/22/2013
                                                              S.A.
72   ANTARA             Capsules          43 mg               Lupin Atlantis Holdings,   02/22/2013
                                                              S.A.
73   ARAVA              Tablets           20 mg               Sanofi Aventis US LLC      09/07/2015
74   ARAVA              Tablets           10 mg               Sanofi Aventis US LLC      09/07/2015
75   ARICEPT            Film coated       5 mg                Eisai, Inc.                11/25/2009 - 11/24/2010
                        tablets
76   ARICEPT            Film coated       10 mg               Eisai, Inc.                11/25/2009 - 11/24/2010
                        tablets
                                                                                          Date Authorized
     Proprietary Name    Dosage Form               Strength     NDA Applicant Name            Generic
                                                                                        Entered the Market
77   ARICEPT ODT        Orally           10 mg                Eisai, Inc.             10/18/2009 - 11/24/2010
                        disintegrating
                        tablets
78   ARICEPT ODT        Orally           5 mg                 Eisai, Inc.             10/18/2009 - 11/24/2010
                        distinegrating
                        tablets
79   ARIXTRA            Injection        10 mg / 0.8 mL       Mylan Ireland Limited   12/2014 - 12/2015
80   ARIXTRA            Injection        7.5 mg / 0.6 mL      Mylan Ireland Limited   12/2014 - 12/2015
81   ARIXTRA            Injection        5 mg / 0.4 mL        Mylan Ireland Limited   12/2014 - 12/2015
82   ARIXTRA            Injection        2.5 mg / 0.5 mL      Mylan Ireland Limited   12/2014 - 12/2015
83   AROMASIN           Tablets          25 mg                Pharmacia & Upjohn      11/02/2010
84   ARTHROTEC          Tablets          50 mg/200 mcg        GD Searle LLC           07/10/2011
85   ARTHROTEC          Tablets          75 mg/200 mcg        GD Searle LLC           07/10/2011
86   ASTELIN            Nasal Spray      137 mcg              Meda Pharmaceuticals,   8/31/2010
                                                              Inc.
87   ATACAND            Tablets          32 mg                AstraZeneca             05/21/2013
                                                              Pharmaceuticals
88   ATACAND            Tablets          8 mg                 AstraZeneca             05/21/2013
                                                              Pharmaceuticals
89   ATACAND            Tablets          4 mg                 AstraZeneca             05/21/2013
                                                              Pharmaceuticals
90   ATACAND            Tablets          16 mg                AstraZeneca             05/21/2013
                                                              Pharmaceuticals
91   ATIVAN             Injection        2 mg/mL              Baxter Healthcare       10/31/2003
                                                              Corporation
                                                                                                    Date Authorized
      Proprietary Name    Dosage Form                Strength         NDA Applicant Name                Generic
                                                                                                  Entered the Market
92    ATIVAN             Injection         4 mg/mL                   Baxter Healthcare          10/31/2003
                                                                     Corporation
93    ATRALIN            Gel               0.05%                     Dow Pharmaceutical         06/19/2014
                                                                     Sciences, a Division of
                                                                     VPNA
94    ATRALIN            Gel               0.05%                     Dow Pharmaceutical         07/26/2007
                                                                     Sciences, a Divison of
                                                                     VPNA
95    AUGMENTIN          Oral              250 mg/62.5 mg per 5 mL   Dr. Reddy's Laboratories   10/1990
                         Suspension                                  Inc.
96    AUGMENTIN          Oral              200 mg/28.5 mg per 5 mL   Dr. Reddy's Laboratories   10/22/1990
                         Suspension                                  Inc.
97    AUGMENTIN          Oral              400 mg/57 mg per 5 mL     Dr. Reddy's Laboratories   10/22/1990
                         Suspension                                  Inc.
98    AUGMENTIN          Tablets           250 mg                    Dr. Reddy's Laboratories   10/22/1990
                                                                     Inc.
99    AUGMENTIN          Tablets           500 mg                    Dr. Reddy's Laboratories   10/22/1990
                                                                     Inc.
100   AUGMENTIN          Tablets           875 mg                    Dr. Reddy's Laboratories   10/02/1996
                                                                     Inc.
101   AUGMENTIN ES-600   Powder for Oral   600 mg/42.9 mg per 5 mL   Dr. Reddy's Laboratories   06/22/2001
                         Suspension                                  Inc.
102   AVALIDE            Tablets           300 mg/12.5 mg            Sanofi-Aventis LLC         09/01/2011 - 08/31/2012
103   AVALIDE            Tablets           150 mg/12.5 mg            Sanofi-Aventis LLC         09/01/2011 - 08/31/2012
104   AVAPRO             Tablets           75 mg                     Sanofi-Aventis LLC         09/01/2011 - 08/31/2012
105   AVAPRO             Tablets           150 mg                    Sanofi-Aventis LLC         09/01/2011 - 08/31/2012
                                                                                              Date Authorized
      Proprietary Name    Dosage Form                Strength    NDA Applicant Name               Generic
                                                                                            Entered the Market
106   AVAPRO             Tablets           300 mg               Sanofi-Aventis LLC        09/01/2011 - 08/31/2012
107   AVELOX             Tablets           400 mg               Bayer HealthCare          Unknown
                                                                Pharmaceuticals
108   AVITA              Cream             0.025%               Mylan Pharmaceuticals,    05/01/1998
                                                                Inc.
109   AXERT              Tablets           6.25 mg              Janssen Research &        07/2015
                                                                Development, LLC
110   AXERT              Tablets           12.5 mg              Janssen Research &        07/2015
                                                                Development, LLC
111   AZILECT            Tablets           1 mg                 Teva Neuroscience, Inc.   01/2017
112   AZILECT            Tablets           0.5 mg               Teva Neuroscience, Inc.   01/2017
113   AZOR               Tablets           5 mg/ 40 mg          Daiichi Sankyo Inc.       10/2016
114   AZOR               Tablets           5 mg/20 mg           Daiichi Sankyo Inc.       10/2016
115   AZOR               Tablets           10 mg/ 40 mg         Daiichi Sankyo Inc.       10/2016
116   AZOR               Tablets           10 mg/ 20 mg         Daiichi Sankyo Inc.       10/2016
117   AZULFIDINE         Tablets           500 mg               Pharmacia and Upjohn      07/14/2003
                                                                Company
118   AZULFIDINE EN-     Delayed-release   500 mg               Pharmacia and Upjohn      06/17/2003
      TABS               Tablets                                Company
119   BENICAR            Tablets           5 mg                 Daiichi Sankyo, Inc       10/2016
120   BENICAR            Tablets           20 mg                Daiichi Sankyo, Inc       10/2016
121   BENICAR            Tablets           40 mg                Daiichi Sankyo, Inc       10/2016
122   BENICAR HCT        Tablets           20 mg/12.5 mg        Daiichi Sankyo, Inc       10/2016
123   BENICAR HCT        Tablets           40 mg/12.5 mg        Daiichi Sankyo, Inc       10/2016
124   BENICAR HCT        Tablets           40 mg/25 mg          Daiichi Sankyo, Inc       10/2016
                                                                                                       Date Authorized
      Proprietary Name    Dosage Form              Strength              NDA Applicant Name                Generic
                                                                                                     Entered the Market
125   BENZACLIN          Topical Gel    1% / 5%                     Valeant Pharmaceuticals        05/2017
                                                                    North Americal LLC
126   BENZAMYCIN         Topical Gel    3% Erythromycin, 5% Benzoyl Valeant Pharmaceuticals        10/2014 - 10/2015
                                        Peroxide                    North America LLC
127   BENZAMYCIN         Topical Gel    3% Erythromycin, 5% Benzoyl Valeant Pharmaceuticals        10/26/1984, 05/07/2013
                                        Peroxide                    North America LLC
128   BETAGAN            Ophthalmic     0.5%                        Allergan, Inc.                 07/15/1997
                         Solution
129   BETAGAN            Ophthalmic     0.25%                           Allergan, Inc.             07/15/1997
                         Solution
130   BETOPTIC           Ophthalmic     eq. 0.5% base                   Alcon Laboratories, Inc.   05/08/2000
                         Solution
131   BIAXIN             Granules for   250 mg per 5 mL when            AbbVie Inc.                05/2012
                         Oral           reconstituted (100 mL bottle)
                         Suspension
132   BIAXIN             Granules for   125 mg per 5 mL when            AbbVie Inc.                05/2012
                         Oral           reconstituted (50 mL bottle)
                         Suspension
133   BLOCADREN          Tablets        5 mg                            Merck & Co., Inc.          Prior to 1/1/1999
134   BLOCADREN          Tablets        10 mg                           Merck & Co., Inc.          Prior to 1/1/1999
135   BREVIBLOC          Injection      10 mg/mL                        Baxter Healthcare          11/2002 - 10/2003
                                                                        Corporation
136   BROMDAY            Ophthalmic     0.09%                           Bausch & Lomb Inc.         10/16/2013
                         Solution
137   BUMEX              Tablets        0.5 mg                          Validus Pharmaceuticals    10/2015
                                                                        LLC
                                                                                              Date Authorized
      Proprietary Name    Dosage Form                Strength    NDA Applicant Name               Generic
                                                                                            Entered the Market
138   BUMEX              Tablets        1 mg                    Validus Pharmaceuticals   10/2015
                                                                LLC
139   BUMEX              Tablets        2 mg                    Validus Pharmaceuticals   10/2015
                                                                LLC
140   BUTRANS            Transdermal    5 mcg/hour              Purdue Pharma L.P.        05/2017
                         System
141   BUTRANS            Transdermal    10 mcg/hour             Purdue Pharma L.P.        05/2017
                         System
142   BUTRANS            Transdermal    20 mcg/hour             Purdue Pharma L.P.        05/2017
                         System
143   BUTRANS            Transdermal    15 mcg/hour             Purdue Pharma L.P.        05/2017
                         System
144   CADUET             Tablet         5 mg/40 mg              PF Prism C.V.             04/04/2014
145   CADUET             Tablet         10 mg/10 mg             PF Prism C.V.             04/04/2014
146   CADUET             Tablet         5 mg/80 mg              PF Prism C.V.             04/04/2014
147   CADUET             Tablet         2.5 mg/40 mg            PF Prism C.V.             04/04/2014
148   CADUET             Tablet         5 mg/10 mg              PF Prism C.V.             04/04/2014
149   CADUET             Tablet         2.5 mg/20 mg            PF Prism C.V.             04/04/2014
150   CADUET             Tablet         10 mg/20 mg             PF Prism C.V.             04/04/2014
151   CADUET             Tablet         2.5 mg/10 mg            PF Prism C.V.             04/04/2014
152   CADUET             Tablet         10 mg/80 mg             PF Prism C.V.             04/04/2014
153   CADUET             Tablet         10 mg/40 mg             PF Prism C.V.             04/04/2014
154   CADUET             Tablet         5 mg/20 mg              PF Prism C.V.             04/04/2014
155   CARAC              Cream          0.5%                    Valeant Pharmaceuticals   10/28/2014
                                                                North America LLC
                                                                                               Date Authorized
      Proprietary Name    Dosage Form                 Strength    NDA Applicant Name               Generic
                                                                                             Entered the Market
156   CARAFATE           Tablets        1g                       Allergan Sales, LLC       11/01/1996
157   CARBATROL          Extended-      300 mg                   Shire Development LLC     12/15/2011
                         Release
                         Capsules
158   CARBATROL          Extended-      200 mg                   Shire Development LLC     12/15/2011
                         Release
                         Capsules
159   CARBATROL          Extended-      100 mg                   Shire Development LLC     12/15/2011
                         Release
                         Capsules
160   CARDIOLITE         Injection      (per label)              Lantheus Medical          12/1990
                                                                 Imaging, Inc.
161   CARDIZEM           Tablets        30 mg                    Valeant Pharmaceuticals   Prior to 1/1/1999
                                                                 North American LLC
162   CARDIZEM           Tablets        60 mg                    Valeant Pharmaceuticals   Prior to 1/1/1999
                                                                 North American LLC
163   CARDIZEM           Tablets        90 mg                    Valeant Pharmaceuticals   Prior to 1/1/1999
                                                                 North American LLC
164   CARDIZEM           Tablets        120 mg                   Valeant Pharmaceuticals   Prior to 1/1/1999
                                                                 North American LLC
165   CARDIZEM CD        Capsules       360 mg                   Valeant Pharmaceuticals   08/09/2012
                                                                 North America, LLC
166   CARDIZEM LA        Tablets        300 mg                   Valeant Pharmaceuticals   02/06/2014
                                                                 North America, LLC
167   CARDIZEM LA        Tablets        360 mg                   Valeant Pharmaceuticals   02/06/2014
                                                                 North America, LLC
                                                                                                     Date Authorized
      Proprietary Name     Dosage Form              Strength             NDA Applicant Name              Generic
                                                                                                   Entered the Market
168   CARDIZEM LA         Tablets        180 mg                        Valeant Pharmaceuticals   02/06/2014
                                                                       North America, LLC
169   CARDIZEM LA       Tablets          420 mg                        Valeant Pharmaceuticals   02/06/2014
                                                                       North America, LLC
170   CARDIZEM LA       Tablets          240 mg                        Valeant Pharmaceuticals   02/06/2014
                                                                       North America, LLC
171   CARNITOR          Oral Solution    1 gm/10 mL                    Sigma-Tau                 04/2005 - 04/2006
                                                                       Pharmaceuticals, Inc.
172   CARNITOR          Tablets          330 mg                        Sigma-Tau                 1/2005 - 12/2005
                                                                       Pharmaceuticals, Inc.
173   CEDAX             Capsules         400 mg                        Pernix Therapeutics LLC   10/22/2013
174   CEDAX             Powder, for Oral 60 mL when reconstituted (180 Pernix Therapeutics LLC   10/22/2013
                        Suspension       mg per 5 mL)
175   CELEBREX          Capsules         200 mg                        G.D. Searle, LLC          12/10/2014
176   CELEBREX          Capsules         400 mg                        G.D. Searle, LLC          12/10/2014
177   CELEBREX          Capsules         100 mg                        G.D. Searle, LLC          12/10/2014
178   CELEBREX          Capsules         50 mg                         G.D. Searle, LLC          12/10/2014
179   CELEBREX          Capsules         200 mg                        G.D. Searle, LLC          12/10/2014
180   CELEBREX          Capsules         100 mg                        G.D. Searle, LLC          12/10/2014
181   CELEBREX          Capsules         200 mg                        G.D. Searle, LLC          12/10/2014
182   CELEBREX          Capsules         100 mg                        G.D. Searle, LLC          12/10/2014
183   CELEBREX          Capsules         200 mg                        G.D. Searle, LLC          12/10/2014
184   CHILDREN'S MOTRIN Suspension       100 mg/5 mL                   McNeil Consumer           06/1998 - 06/1999
                                                                       Healthcare
                                                                                                   Date Authorized
      Proprietary Name     Dosage Form               Strength        NDA Applicant Name                  Generic
                                                                                                 Entered the Market
185   CHILDREN'S MOTRIN   Suspension/     40 mg/mL                  McNeil Consumer            Prior to 1/1/1999
      (aka INFANT'S       Drops                                     Healthcare
      MOTRIN)
186   CILOXAN             Ophthalmic      0.3%                      Novartis Pharmaceuticals   05/28/2004
                          Solution                                  Corporation
187   CIPRO               for Oral        250 mg/5 mL               Bayer Pharmaceuticals      06/2003
                          Suspension                                Corp.
188   CIPRO               for Oral        500 mg/5 mL               Bayer Pharmaceuticals      06/2003
                          Suspension                                Corp.
189   CIPRO               Tablets         eq. 250 mg base           Bayer Pharmaceuticals      Prior to 1/1/1999
                                                                    Corp.
190   CIPRO               Tablets         eq. 500 mg base           Bayer Pharmaceuticals      Prior to 1/1/2000
                                                                    Corp.
191   CIPRO               Tablets         eq. 750 mg base           Bayer Pharmaceuticals      Prior to 1/1/2001
                                                                    Corp.
192   CLEOCIN             Vaginal Cream   2%                        Pharmacia and Upjohn       12/17/2005
                                                                    Company
193   CLEOCIN HCl         Capsules        150 mg                    Pharmacia and Upjohn       07/11/2003
                                                                    Company
194   CLEOCIN HCl         Capsules        300 mg                    Pharmacia and Upjohn       06/18/2003
                                                                    Company
195   CLEOCIN PEDIATRIC   Flavored        75 mg/5 mL (100 mL when   Pharmacia and Upjohn       07/28/2010
                          Granules for    mixed)                    Company
                          Oral Solution
196   CLEOCIN T           Topical Gel     1%                        Pharmacia and Upjohn       06/11/2003
                                                                    Company
                                                                                                  Date Authorized
      Proprietary Name    Dosage Form              Strength          NDA Applicant Name               Generic
                                                                                                Entered the Market
197   CLEOCIN T          Topical Lotion   1%                        Pharmacia and Upjohn      06/18/2003
                                                                    Company
198   CLEOCIN T          Topical          1%                        Pharmacia and Upjohn      06/11/2003
                         Solution                                   Company
199   CLINORIL           Tablets          150 mg                    Merck & Co., Inc.         Prior to 1/1/1999
200   CLINORIL           Tablets          200 mg                    Merck & Co., Inc.         Prior to 1/1/1999
201   CLOBEX             Emulsion,        0.05%                     Galderma Laboratories,    01/03/2012
                         Lotion                                     L.P.
202   CLOBEX             Shampoo          0.05%                     Galderma Laboratories,    12/2011
                                                                    LP
203   CLOBEX             Spray            0.05%                     Galderma Laboratories,    08/2015
                                                                    L.P.
204   CLODERM            Cream            0.1%                      Promius Pharma, LLC       02/17/2014
205   CLOLAR             Injection        20mg/20mL                 Genzyme Corporation       05/2017
206   CLOMID             Tablets          50 mg                     Hoechst Marion Roussel,   Prior to 1/1/1999
                                                                    Inc.
207   CLOZARIL           Tablets          100 mg                    Heritage Life Sciences    09/2017
                                                                    (USA), Inc.
208   CLOZARIL           Tablets          25 mg                     Heritage Life Sciences    09/2017
                                                                    (USA), Inc.
209   COGENTIN           Injection        2 mg/2 mL (2 mL ampule)   Oak Pharmaceuticals       08/08/2012
210   COLAZAL            Capsules         750 mg                    Salix Pharmaceuticals,    01/2008
                                                                    Inc.
211   COLCRYS            Tablets          0.6 mg                    Takeda Pharmaceuticals    01/09/2015
                                                                    U.S.A. Inc.
                                                                                                          Date Authorized
      Proprietary Name    Dosage Form                 Strength               NDA Applicant Name               Generic
                                                                                                        Entered the Market
212   COLESTID           Granules for      5 g per dose                     Pharmacia and Upjohn      01/11/2016
                         Oral                                               Company
                         Suspension
213   COLESTID           Tablets           1g                               Pharmacia and Upjohn      02/2007
214   COLY-MYCIN M       for Injection     150 mg/vial (single dose vial)   Par Sterile Products, LLC 06/01/2012
215   COLYTE             Powder for Oral   240 gm/bottle PEG 3350 (5.84;    Mylan Specialty, L.P.     10/1996
                         Solution          2.98; 6.72; 22.72 gm/bottle
                                           other)
216   COMTAN             Tablets           200 mg                           Orion Corporation         06/04/2014
217   COMTAN             Tablets           200 mg                           Orion Corporation         6/26/2013
218   COMTAN             Tablets           200 mg                           Orion Corporation         10/1/2012
219   COMTAN             Tablets           200 mg                           Orion Corporation         4/1/2013
220   CONCERTA           Extended-         18 mg                            Janssen Research and      5/1/2011
                         release Tablets                                    Development, LLC
221   CONCERTA           Extended-         27 mg                            Janssen Research and      5/1/2011
                         release Tablets                                    Development, LLC
222   CONCERTA           Extended-         36 mg                            Janssen Research and      5/1/2011
                         release Tablets                                    Development, LLC
223   CONCERTA           Extended-         54 mg                            Janssen Research and      5/1/2011
                         release Tablets                                    Development, LLC
224   CONDYLOX           Topical           0.5%                             Allergan Sales, LLC       12/16/2003
                         Solution
225   CONZIP             Extended-         200 mg                           Cipher Pharmaceuticals,   05/2015
                         release                                            Inc.
                         Capsules
                                                                                                     Date Authorized
      Proprietary Name    Dosage Form               Strength          NDA Applicant Name                 Generic
                                                                                                   Entered the Market
226   CONZIP             Extended-       150 mg                      Cipher Pharmaceuticals,     06/2012
                         release                                     Inc.
                         Capsules
227   CONZIP             Extended-       300 mg                      Cipher Pharmaceuticals,     06/2015
                         release                                     Inc.
                         Capsules
228   CONZIP             Extended-       100 mg                      Cipher Pharmaceuticals,     06/2015
                         release                                     Inc.
                         Capsules
229   CORGARD            Tablets         80 mg                       US WorldMeds, LLC           05/05/2014
230   CORGARD            Tablets         20 mg                       US WorldMeds, LLC           05/05/2014
231   CORGARD            Tablets         40 mg                       US WorldMeds, LLC           05/05/2014
232   CORTEF             Tablets         20 mg                       Pharmacia and Upjohn        12/22/2012
                                                                     Company LLC
233   CORTEF             Tablets         5 mg                        Pharmacia and Upjohn        12/21/2012
                                                                     Company LLC
234   CORTEF             Tablets         10 mg                       Pharmacia and Upjohn        12/21/2012
                                                                     Company LLC
235   CORTENEMA          Rectal          100 mg/60 mL                ANI Pharmaceuticals, Inc.   08/2012
                         Suspension
236   CORTISPORIN OTIC   Otic Solution   eq. 3.5 mg base/g; 10,000   Monarch Pharmaceuticals 1/11/1999
                                         units/g; 1%                 Inc.
237   COSMEGEN           Powder, for     500 mcg (0.5 mg)            Recordati Rare Diseases 12/2017
                         injection                                   Inc.
                         solution,
                         lyophilized
                                                                                                          Date Authorized
      Proprietary Name    Dosage Form               Strength               NDA Applicant Name                 Generic
                                                                                                        Entered the Market
238   COZAAR             Tablet, Film     25 mg                           Merck Sharp & Dohme         4/6/2010
                         Coated                                           Corp.
239   COZAAR             Tablet, Film     50 mg                           Merck Sharp & Dohme         4/6/2010
                         Coated                                           Corp.
240   COZAAR             Tablet, Film     100 mg                          Merck Sharp & Dohme         4/6/2010
                         Coated                                           Corp.
241   CUTIVATE           Cream            0.05%                           GlaxoSmithKline             11/2003 - 11/2004
                                                                          Consumer Healthcare
242   CUTIVATE           Lotion           0.05%                           Fougera Pharmaceuticals,    10/05/2009
                                                                          Inc.
243   CUTIVATE           Ointment         0.005%                          GlaxoSmithKline             11/2003 - 11/2004
                                                                          Consumer Healthcare
244   CYCLESSA           Tablets          0.1 mg, 0.125 mg, 0.15 mg;      Organon USA Inc.            9/15/2004
                                          0.025 mg, 0.025 mg, 0.025 mg
245   CYTOTEC            Tablets          100 mcg                         GD Searle LLC               06/18/2003
246   CYTOTEC            Tablets          200 mcg                         GD Searle LLC               06/18/2003
247   DANTRIUM           Capsules         100 mg                          Par Sterile Products, LLC   02/2016
248   DANTRIUM           Capsules         25 mg                           Par Sterile Products, LLC   04/08/2013
249   DANTRIUM           Capsules         50 mg                           Par Sterile Products, LLC   04/08/2013
250   DAYPRO             Tablets          600 mg                          GD Searle LLC               03/28/2013
251   DDAVP              Nasal Solution   0.1 mL (10 mcg) per actuation   Ferring Pharmaceuticals,    07/2016
                                                                          Inc.
252   DDAVP              Tablets          0.2 mg                          Ferring Pharmaceuticals,    12/2015
                                                                          Inc.
253   DDAVP              Tablets          0.1 mg                          Ferring Pharmaceuticals,    12/2015
                                                                          Inc.
                                                                                                   Date Authorized
      Proprietary Name     Dosage Form               Strength        NDA Applicant Name                Generic
                                                                                                 Entered the Market
254   DDAVP,             Injection        4 mcg/mL                  Ferring Pharmaceuticals    01/2016
      DESMOPRESSIN                                                  Inc.
      ACETATE
255   DELESTROGEN       Injection         20 mg/mL                  Par Sterile Products       06/01/2012
256   DELESTROGEN       Injection         10 mg/mL                  Par Sterile Products       06/01/2012
257   DELESTROGEN       Injection         40 mg/mL                  Par Sterile Products       06/01/2012
258   DEPAKOTE ER       Extended-         500 mg                    Abbvie Inc.                08/2013
                        release Tablets
259   DEPAKOTE ER       Extended-         250 mg                    Abbvie Inc.                08/2013
                        release Tablets
260   DEPAKOTE SPRINKLE Capsules          125 mg                    AbbVie Inc.                08/31/2015
      CAPSULES
261   DEPO-MEDROL        Injection        40 mg/mL                  Pharmacia and Upjohn       05/2006 - 05/2007
262   DEPO-MEDROL        Injection        80 mg/mL                  Pharmacia and Upjohn       05/2006 - 05/2007
263   DEPO-PROVERA       Injection        150 mg/mL                 Pharmacia and Upjohn       09/16/2004
264   DERMA-             Oil              0.01%                     Hill Dermaceuticals Inc.   08/20/2013
      SMOOTHE/FS
265   DERMATOP           Cream            0.1%                      Valeant Pharmaceuticals    10/2006 - 10/2007
      EMOLLIENT CREAM                                               North America, LLC
266   DERMOTIC           Oil              0.01%                     Hill Dermaceuticals Inc.   08/2013
267   DESMOPRESSIN       Nasal Spray      10 mcg per 0.1 mL (5 mL   Ferring Pharmaceuticals,   11/20/2014
      ACETATE                             bottle)                   Inc.
268   DESOWEN            Cream            0.05%                     Galderma Laboratories,     07/2013
                                                                    L.P.
269   DETROL             Tablets          1 mg                      Pharmacia and Upjohn       01/23/2014
270   DETROL             Tablets          2 mg                      Pharmacia and Upjohn       01/23/2014
                                                                                            Date Authorized
      Proprietary Name    Dosage Form             Strength    NDA Applicant Name                Generic
                                                                                          Entered the Market
271   DETROL             Tablets        1 mg                 Pharmacia and Upjohn       06/7/2012, 03/13/2015
272   DETROL             Tablets        2 mg                 Pharmacia and Upjohn       06/07/2012, 03/13/2015
273   DETROL LA          Extended-      4 mg                 Pharmacia and Upjohn       01/02/2014
                         release
                         Capsules
274   DETROL LA          Extended-      2 mg                 Pharmacia and Upjohn       01/02/2014
                         release
                         Capsules
275   DEXEDRINE          Extended-      5 mg                 Impax Laboratories, Inc.   08/02/1976
      SPANSULE           release
                         Capsules
276   DEXEDRINE          Extended-      15 mg                Impax Laboratories, Inc.   08/02/1976
      SPANSULE           release
                         Capsules
277   DEXEDRINE          Extended-      10 mg                Impax Laboratories, Inc.   08/02/1976
      SPANSULE           release
                         Capsules
278   DIABETA            Tablets        1.25 mg              Sanofi-Aventis U.S., LLC   05/01/1984
279   DIAMOX SEQUELS     Extended-      500 mg               Teva Branded               12/2008
                         release                             Pharmaceutical Products
                         Capsules                            R&D, Inc.
280   DIASTAT            Gel            10 mg                Valeant Pharmaceuticals    09/03/2010
                                                             North America LLC
281   DIASTAT            Gel            2.5 mg               Valeant Pharmaceuticals    10/01/2010
                                                             North America LLC
282   DIASTAT            Gel            20 mg                Valeant Pharmaceuticals    09/03/2010
                                                             North America LLC
                                                                                                        Date Authorized
      Proprietary Name     Dosage Form                Strength             NDA Applicant Name               Generic
                                                                                                      Entered the Market
283   DIAZEPAM            Gel               2.5 mg                        Valeant Pharmaceuticals   09/03/2010
                                                                          North America, LLC
284   DIAZEPAM            Gel               10 mg                         Valeant Pharmaceuticals   09/03/2010
                                                                          North America, LLC
285   DIAZEPAM            Gel               20 mg                         Valeant Pharmaceuticals   09/03/2010
                                                                          North America, LLC
286   DIBENZYLINE         Capsules          10 mg                         Concordia                 08/11/2015
                                                                          Pharmaceuticals Inc.
287   DIFFERIN GEL 0.1%   Gel               0.1%                          Galderma Laboratories,    08/23/2010
                                                                          L.P.
288   DIFFERIN GEL 0.3%   Gel               0.3%                          Galderma Laboratories,    09/2009
                                                                          L.P.
289   DIFFERIN GEL 0.3%   Gel               0.3%                          Galderma Laboratories,    01/2014
                                                                          L.P.
290   DIFLUCAN            Powder for Oral   10 mg/mL when reconstituted   Pfizer Inc.               03/12/2004
                          Suspension
291   DIFLUCAN            Powder for Oral   40 mg/mL when reconstituted   Pfizer Inc.               03/12/2004
                          Suspension
292   DIFLUCAN            Tablets           50 mg                         Pfizer Inc.               03/12/2004
293   DIFLUCAN            Tablets           100 mg                        Pfizer Inc.               03/12/2004
294   DIFLUCAN            Tablets           150 mg                        Pfizer Inc.               03/12/2004
295   DIFLUCAN            Tablets           200 mg                        Pfizer Inc.               03/12/2004
296   DILANTIN            Tablet            50 mg                         Parke-Davis Division of   12/27/2012
                          (INFATABS)                                      Pfizer Inc.
297   DILANTIN-125        Oral              125 mg/5 mL (237 mL bottle)   Parke-Davis Division of   6/13/2012
                          Suspension                                      Pfizer Inc.
                                                                                                           Date Authorized
      Proprietary Name    Dosage Form                 Strength              NDA Applicant Name                 Generic
                                                                                                         Entered the Market
298   DILAUDID           Solution          5 mg/5 mL (1 mg/mL)              Rhodes Pharmaceuticals     10/1/2012
                                                                            L.P.
299   DILAUDID           Tablets           8 mg                             Rhodes Pharmaceuticals     11/23/2009
                                                                            L.P.
300   DILAUDID           Tablets           2 mg                             Rhodes Pharmaceuticals     11/23/2009
                                                                            L.P.
301   DILAUDID           Tablets           4 mg                             Rhodes Pharmaceuticals     11/23/2009
                                                                            L.P.
302   DIPROLENE          Ointment          0.05%                            Merck Sharp & Dohme        8/10/2012
                                                                            Corporation
303   DITROPAN XL        Extended-         5 mg                             Janssen Research and       11/12/2015
                         release Tablets                                    Development, LLC
304   DITROPAN XL        Extended-         10 mg                            Janssen Research and       11/12/2015
                         release Tablets                                    Development, LLC
305   DIURIL             Injection         500 mg/vial, sterile lyophilized Oak Pharmaceuticals Inc.   08/13/2012
306   DOLOPHINE          Tablets           5 mg                             West-Ward                  1999 - 2000
                                                                            Pharmaceuticals Corp.
307   DOLOPHINE          Tablets           10 mg                            West-Ward                  1999 - 2000
                                                                            Pharmaceuticals Corp.
308   DORAL              Tablets           15 mg                            Galt Pharmaceuticals,      8/8/13
                                                                            LLC
309   DORIBAX            Powder for        250 mg/vial                      Shionogi Inc.              12/2016
                         Injection
310   DORIBAX            Powder for        500 mg/vial                     Shionogi Inc.               12/2016
                         Injection
                                                                                                     Date Authorized
      Proprietary Name    Dosage Form                Strength             NDA Applicant Name             Generic
                                                                                                    Entered the Market
311   DORYX              Delayed-Release   50 mg                         Mayne Pharma             Unknown
                         Tablets                                         International Pty Ltd.
312   DORYX              Delayed-Release   100 mg                        Mayne Pharma             07/08/2013
                         Tablets                                         International Pty Ltd.
313   DORYX              Delayed-Release   150 mg                        Mayne Pharma             07/08/2013
                         Tablets                                         International Pty Ltd.
314   DORYX              Delayed-Release   75 mg                         Mayne Pharma             07/08/2013
                         Tablets                                         International Pty Ltd.
315   DORYX              Delayed-Release   200 mg                        Mayne Pharma             2016
                         Tablets                                         International Pty Ltd.
316   DOSTINEX           Tablets           0.5 mg                        Pharmacia and Upjohn     09/22/2014
                                                                         LLC
317   DOVONEX            Cream             0.005%                        LEO Pharma Inc.          2012
318   DOVONEX            Ointment          0.005%                        LEO Pharma Inc.          07/01/2013
319   DOXIL              Injection         50 mg/25 mL single use vial   Janssen Research &       07/2017
                         (Liposomal                                      Development, LLC
                         formulation)
320   DOXIL              Injection         20 mg/10 mL single use vial   Janssen Research &       07/2017
                         (Liposomal                                      Development, LLC
                         formulation)
321   DOXORUBICIN        Injection         20 mg/10 mL                   Pharmacia and Upjohn     4/1/2013
322   DOXORUBICIN        Injection         50 mg/25 mL                   Pharmacia and Upjohn     4/1/2013
323   DOXORUBICIN        Injection         200 mg/ 100 mL                Pharmacia and Upjohn     03/17/2014
324   DOXORUBICIN        Injection         50 mg/25 mL                   Pharmacia and Upjohn     03/17/2014
325   DOXORUBICIN        Injection         20 mg/10mL                    Pharmacia and Upjohn     03/17/2014
326   DOXORUBICIN        Injection         10 mg/5 mL                    Pharmacia and Upjohn     03/17/2014
                                                                                                       Date Authorized
      Proprietary Name    Dosage Form                Strength          NDA Applicant Name                  Generic
                                                                                                     Entered the Market
327   DOXORUBICIN        Injection      10 mg/5 mL                    Pharmacia and Upjohn         4/1/2013
328   DOXORUBICIN        Injection      150 mg/75 mL                  Pharmacia and Upjohn         4/1/2013
329   DOXORUBICIN        Injection      200 mg/100 mL                 Pharmacia and Upjohn         4/1/2013
330   DRISDOL            Capsules       1.25 mg (50,000 IU)           Sanofi Aventis US LLC        11/10/2009
331   DUAC               Topical Gel    1.2% Clindamycin Phosphate,   Stiefel Laboratories, Inc.   06/27/2012
                                        5% Benzoyl Peroxide
332   DUETACT            Tablets        30 mg / 4 mg                  Takeda Pharmaceuticals       08/04/2015
                                                                      U.S.A., Inc.
333   DUETACT            Tablets        30 mg / 2 mg                  Takeda Pharmaceuticals       08/04/2015
                                                                      U.S.A., Inc.
334   DURAGESIC-100      Transdermal    100 mcg/h                     Janssen Research &           2009
                         System                                       Development, LLC
335   DURAGESIC-12       Transdermal    12 mcg/h                      Janssen Research &           2009
                         System                                       Development, LLC
336   DURAGESIC-25       Transdermal    25 mcg/h                      Janssen Research &           2009
                         System                                       Development, LLC
337   DURAGESIC-50       Transdermal    50 mcg/h                      Janssen Research &           2009
                         System                                       Development, LLC
338   DURAGESIC-75       Transdermal    75 mcg/h                      Janssen Research &           2009
                         System                                       Development, LLC
339   DUTOPROL           Tablets        25/12.5 mg                    Concordia                    08/2017
                                                                      Pharmaceuticals Inc.
340   DUTOPROL           Tablets        100/12.5 mg                   Concordia                    08/2017
                                                                      Pharmaceuticals Inc.
341   EDECRIN            Tablets        25 mg                         Aton Pharma, Inc.            01/2016 - 01/2017
                                                                                                   Date Authorized
      Proprietary Name    Dosage Form             Strength          NDA Applicant Name                 Generic
                                                                                                 Entered the Market
342   EFFEXOR XR         Extended-      150 mg                     Wyeth Pharmaceuticals       6/1/2008
                         release
                         Capsules
343   EFFEXOR XR         Extended-      75 mg                      Wyeth Pharmaceuticals       6/1/2008
                         release
                         Capsules
344   EFFEXOR XR         Extended-      37.5 mg                    Wyeth Pharmaceuticals       6/1/2008
                         release
                         Capsules
345   EFUDEX             Cream          5% Topical Cream           Valeant Pharmaceuticals     09/2006
                                                                   International, Inc.
346   ELDEPRYL           Capsules       5 mg                       Somerset Pharmaceuticals,   05/1998 - 05/1999
                                                                   Inc.
347   ELDEPRYL           Tablets        5 mg                       Somerset Pharmaceuticals,   06/1999 - 06/2000
                                                                   Inc.
348   ELOXATIN           Injection      50 mg / 10 mL (5 mg/mL)    Sanofi-Aventis US LLC       07/07/2014
349   ELOXATIN           Injection      100 mg / 20 mL (5 mg/mL)   Sanofi-Aventis US LLC       07/07/2014
350   ELOXATIN           Injection      50 mg/10 mL (5 mg/mL)      Sanofi-Aventis US LLC       10/2015
      (PREMIERPro)
351   ELOXATIN           Injection      100 mg / 20 mL (5 mg/mL)   Sanofi-Aventis US LLC       10/2015
      (PREMIERPro)
352   EMLA               Cream          2.5% and 2.5%              Actavis Laboratories UT,    11/12/2012
                                                                   Inc.
353   ENTOCORT EC        Capsules       3 mg                       Paddock Laboratories,       08/18/2011
                                                                   LLC
354   EPIDUO             Topical Gel    0.1% / 2.5%                Galderma Laboratories,      08/2017
                                                                   L.P.
                                                                                                Date Authorized
       Proprietary Name    Dosage Form               Strength       NDA Applicant Name              Generic
                                                                                              Entered the Market
355   EPIPEN              Injection         0.3 mg/0.3 mL          Mylan Specialty L.P.     12/15/2016
356   EPIPEN JR.          Injection         0.15/0.3 mL            Mylan Specialty L.P.     12/15/2016
357   EPIVIR-HBV          Tablets           100 mg                 GlaxoSmithKline          09/05/2014
358   EPZICOM             Tablets           600 mg and 300 mg      ViiV Healthcare          09/2016
                                                                   Company
359   ERYC                Delayed-Release 250 mg                   Mayne Pharma             07/29/2013
                          Capsules                                 International Pty Ltd
360   ERYGEL              Topical Gel     2%                       Mylan Pharmaceuticals,   07/2015
                                                                   Inc.
361   ERYPED              Granule           200 mg per 5 mL when   Arbor Pharmaceuticals    09/2016
                                            reconstituted          LLC
362   EXALGO              Extended-         32 mg                  SpecGx LLC               06/12/2014
                          release Tablets
363   EXALGO              Extended-         16 mg                  SpecGx LLC               06/12/2014
                          release Tablets
364   EXALGO              Extended-         12 mg                  SpecGx LLC               06/12/2014
                          release Tablets
365   EXALGO              Extended-         8 mg                   SpecGx LLC               06/12/2014
                          release Tablets
366   EXELON              Capsule           1.5 mg                 Novartis Pharmaceuticals 07/1/2010
                                                                   Corp.
367   EXELON              Capsule           3 mg                   Novartis Pharmaceuticals 07/1/2010
                                                                   Corp.
368   EXELON              Capsule           4.5 mg                 Novartis Pharmaceuticals 07/1/2010
                                                                   Corp.
                                                                                                  Date Authorized
      Proprietary Name    Dosage Form             Strength            NDA Applicant Name              Generic
                                                                                                Entered the Market
369   EXELON             Capsule        6 mg                         Novartis Pharmaceuticals 07/1/2010
                                                                     Corp.
370   EXFORGE            Tablets        5 mg/320 mg                  Novartis Pharmaceutical 03/2015
                                                                     Corp.
371   EXFORGE            Tablets        10 mg/320 mg                 Novartis Pharmaceutical 03/2015
                                                                     Corp.
372   EXFORGE            Tablets        10 mg/160 mg                 Novartis Pharmaceutical 03/2015
                                                                     Corp.
373   EXFORGE            Tablets        5 mg/160 mg                  Novartis Pharmaceutical 03/2015
                                                                     Corp.
374   EXFORGE HCT        Tablets        5 mg/160 mg/25 mg (each      Novartis Pharmaceutical 12/02/2014
                                        tablet contains 6.9 mg       Corporation
                                        amlodipine besylate)
375   EXFORGE HCT        Tablets        10 mg/160 mg/12.5 mg (each   Novartis Pharmaceutical   12/02/2014
                                        tablet contains 13.9 mg      Corporation
                                        amlodipine besylate)
376   EXFORGE HCT        Tablets        5 mg/160 mg/12.5 mg (each    Novartis Pharmaceutical   12/02/2014
                                        tablet contains 6.9 mg       Corporation
                                        amlodipine besylate)
377   EXFORGE HCT        Tablets        10 mg/320 mg/25 mg (each     Novartis Pharmaceutical   12/02/2014
                                        tablet contains 13.9 mg      Corporation
                                        amlodipine besylate)
378   EXFORGE HCT        Tablets        10 mg/160 mg/25 mg (each     Novartis Pharmaceutical   12/02/2014
                                        tablet contains 13.9 mg      Corporation
                                        amlodipine besylate)
379   FAMVIR             Tablets        125 mg                       Novartis                  03/22/2011
380   FAMVIR             Tablets        250 mg                       Novartis                  03/22/2011
                                                                                                        Date Authorized
       Proprietary Name    Dosage Form               Strength             NDA Applicant Name                Generic
                                                                                                      Entered the Market
381   FAMVIR FAMVIR       Tablets          500 mg                        Novartis                   03/22/2011
382   FAZACLO             Orally           100 mg                        Jazz Pharmaceuticals       8/30/2012
                          Disintegrating
                          Tablets
383   FAZACLO             Orally           25 mg                         Jazz Pharmaceuticals       8/30/2012
                          Disintegrating
                          Tablets
384   FAZACLO             Orally           12.5 mg                       Jazz Pharmaceuticals       8/30/2012
                          Disintegrating
                          Tablets
385   FELBATOL            Oral             600 mg/5 mL                   Mylan Specialty, L.P.      1/2012
                          Suspension
386   FELBATOL            Tablets          600 mg                        Mylan Specialty, L.P.      11/2011
387   FELBATOL            Tablets          400 mg                        Mylan Specialty, L.P.      11/2011
388   FELDENE             Capsules         20 mg                         Pfizer Inc.                03/03/2014
389   FELDENE             Capsules         10 mg                         Pfizer Inc.                03/03/2014
390   FEMCON Fe           Chewable         0.4 mg/35 mcg                 Allergan Pharmaceuticals   10/2011
                          Tablets                                        International Ltd.
391   FENOGLIDE           Tablets          120 mg                        Santarus, Inc.             06/24/2015
392   FENOGLIDE           Tablets          40 mg                         Santarus, Inc.             06/24/2015
393   FIBRICOR            Tablets          105 mg                        Aralez Pharmaceuticals     09/22/2010
                                                                         US, Inc.
394   FIBRICOR            Tablets          35 mg                         Aralez Pharmaceuticals     09/22/2010
                                                                         US, Inc.
395   FIORICET with       Capsules         50 mg / 325 mg / 40 mg / 30   Actavis Laboratories UT,   10/01/2003
      CODEINE                              mg                            Inc.
                                                                                                        Date Authorized
       Proprietary Name    Dosage Form              Strength             NDA Applicant Name                 Generic
                                                                                                      Entered the Market
396   FIORINAL            Capsules       50 mg / 325 mg / 40 mg         Allergan Sales, LLC         10/6/2003
397   FIORINAL with       Capsules       50 mg / 325 mg / 40 mg / 30    Allergan Sales, LLC         10/26/2006
      CODEINE                            mg
398   FLORONE             Cream          0.05%                          Pharmacia and Upjohn        Prior to 1/1/1999
                                                                        Company
399   FLUMADINE           Tablets        100 mg                         Forest Laboratories, Inc.   09/2002 - 09/2003
400   FLUOXETINE          Tablets        60 mg                          Alvogen Group Holdings      09/2017
                                                                        3, LLC
401   FML                 Ophthalmic     0.1%                           Allergan, Inc.              10/1997
                          Suspension
402   FOCALIN XR          Extended-      5 mg                           Novartis Pharmaceuticals 11/12/2014
                          release                                       Corporation
                          Capsules
403   FOCALIN XR          Extended-      15 mg                          Novartis Pharmaceuticals 03/04/2014
                          release                                       Corporation
                          Capsules
404   FOCALIN XR          Extended-      40 mg                          Novartis Pharmaceuticals 03/04/2014
                          release                                       Corporation
                          Capsules
405   FOCALIN XR          Extended-      10 mg                          Novartis Pharmaceuticals 02/03/2015
                          release                                       Corporation
                          Capsules
406   FOCALIN XR          Extended-      30 mg                          Novartis Pharmaceuticals 03/04/2014
                          release                                       Corporation
                          Capsules
407   FORTESA             Gel            10 mg testosterone/actuation   Endo Pharmaceuticals,       08/25/2014
                                                                        Inc.
                                                                                                        Date Authorized
      Proprietary Name    Dosage Form                Strength              NDA Applicant Name               Generic
                                                                                                      Entered the Market
408   FURADANTIN         Oral              25 mg / 5 mL                  Casper Pharma LLC          12/2011 - 12/2012
                         Suspension
409   GABITRIL           Tablets           2 mg                          Cephalon, Inc              12/26/2012
410   GABITRIL           Tablets           4 mg                          Cephaloln, Inc.            12/26/2012
411   GASTROCROM         Oral              100 mg/5 mL (ampule)          Wallace Pharmaceuticals    06/2015
                         Concentrate                                     Inc.
412   GENERESS FE        Chewable          0.8 mg/25 mcg                 Allergan Pharmaceuticals   03/2015
                         Tablets                                         International Ltd.
413   GEODON             Capsules          80 mg                         Pfizer                     12/15/2011
414   GEODON             Capsules          60 mg                         Pfizer                     12/15/2011
415   GEODON             Capsules          40 mg                         Pfizer                     12/15/2011
416   GEODON             Capsules          20 mg                         Pfizer                     12/15/2011
417   GLUCOTROL XL       Extended-         2.5 mg                        Pfizer Inc.                03/11/2004
                         release Tablets
418   GLUCOTROL XL       Extended-         5 mg                          Pfizer Inc.                03/11/2004
                         release Tablets
419   GLUCOTROL XL       Extended-         10 mg                         Pfizer Inc.                03/11/2004
                         release Tablets
420   GOLYTELY           Powder for Oral   PEG-3350 17.6 mmol/L,         Braintree Laboratories,    07/2009
                         Solution          sodium 125 mmol/L, sulfate 40 Inc.
                                           mmol/L, chloride 35 mmol/L,
                                           bicarbonate 20 mmol/L and
                                           potassium 10 mmol/L (per 4
                                           liter jug w/water)
421   GRIS-PEG           Tablets           125 mg                        Valeant Pharmaceuticals    12/03/2012
                                                                         International Inc.
                                                                                                   Date Authorized
      Proprietary Name    Dosage Form                  Strength    NDA Applicant Name                  Generic
                                                                                                 Entered the Market
422   GRIS-PEG           Tablets            250 mg                Valeant Pharmaceuticals      12/03/2012
                                                                  International Inc.
423   HALCION            Tablets            0.25 mg               Pharmacia and Upjohn         6/17/2003
                                                                  Company
424   HALCION            Tablets            0.125 mg              Pharmacia and Upjohn         7/11/2003
                                                                  Company
425   HALDOL             Injection          5 mg/mL               Janssen Pharmaceuticals,     7/2011
                                                                  Inc.
426   HALDOL             Injection          100 mg/mL             Janssen Research &           07/2011
      DECANOATE                                                   Development, LLC
427   HALDOL             Injection          50 mg/mL              Janssen Research &           08/2011
      DECANOATE                                                   Development, LLC
428   HECTOROL           Capsules, liquid   0.5 mcg               Genzyme Corporation          03/11/2014
                         filled
429   HECTOROL           Capsules, liquid   1 mcg                 Genzyme Corporation          03/11/2014
                         filled
430   HECTOROL           Capsules, liquid   2.5 mcg               Genzyme Corporation          03/11/2014
                         filled
431   HIPREX             Tablets            1g                    Validus Pharmaceuticals      06/2016
                                                                  LLC
432   IMITREX            Injection          4 mg/0.5 mL           GlaxoSmithKline              3/29/2012
                                                                  Intellectual Property Ltd.
                                                                  England
433   IMITREX            Injection          6 mg/0.5 mL (Kit)     GlaxoSmithKline              11/2007 - 11/2008
                                                                  Intellectual Property Ltd.
                                                                  England
                                                                                                    Date Authorized
      Proprietary Name    Dosage Form             Strength          NDA Applicant Name                  Generic
                                                                                                  Entered the Market
434   IMITREX            Injection      6 mg/0.5 mL Statdose kit   GlaxoSmithKline              03/29/2012
                                                                   Intellectual Property Ltd.
                                                                   England
435   IMITREX            Injection      6 mg/0.5 mL                GlaxoSmithKline              11/2007 - 11/2008
                                                                   Intellectual Property Ltd.
                                                                   England
436   IMITREX            Injection      4 mg/0.5 mL (Kit)          GlaxoSmithKline              03/29/2012
                                                                   Intellectual Property Ltd.
                                                                   England
437   IMITREX            Nasal Spray    5 mg                       GlaxoSmithKline              10/13/2008
                                                                   Intellectual Property Ltd.
                                                                   England
438   IMITREX            Nasal Spray    20 mg                      GlaxoSmithKline              10/03/2008
                                                                   Intellectual Property Ltd.
                                                                   England
439   INDERAL LA         Extended-      80 mg                      ANI Pharmaceuticals, Inc.    12/2017
                         release
                         Capsules
440   INDERAL LA         Extended-      120 mg                     ANI Pharmaceuticals, Inc. 12/2017
                         release
                         Capsules
441   INDERAL LA         Extended-      60 mg                      ANI Pharmaceuticals, Inc. 12/2017
                         release
                         Capsules
442   INDERAL LA         Extended-      160 mg                     ANI Pharmaceuticals, Inc. 12/2017
                         release
                         Capsules
                                                                                             Date Authorized
      Proprietary Name    Dosage Form               Strength    NDA Applicant Name               Generic
                                                                                           Entered the Market
443   INDERAL LA         Extended-         60 mg               ANI Pharmaceuticals, Inc. 2/25/2009
                         release
                         Capsules
444   INDERAL LA         Extended-         80 mg               ANI Pharmaceuticals, Inc. 2/25/2009
                         release
                         Capsules
445   INDERAL LA         Extended-         120 mg              ANI Pharmaceuticals, Inc. 2/25/2009
                         release
                         Capsules
446   INDERAL LA         Extended-         160 mg              ANI Pharmaceuticals, Inc. 2/25/2009
                         release
                         Capsules
447   INSPRA             Tablets           25 mg               G.D. Searle LLC          09/13/2007
448   INSPRA             Tablets           50 mg               G.D. Searle LLC          09/13/2007
449   INVEGA             Extended-         9 mg                Janssen Research &       09/24/2015
                         release Tablets                       Development, LLC
450   INVEGA             Extended-         6 mg                Janssen Research &       09/24/2015
                         release Tablets                       Development, LLC
451   INVEGA             Extended-         3 mg                Janssen Research &       09/24/2015
                         release Tablets                       Development, LLC
452   INVEGA             Extended-         1.5 mg              Janssen Research &       09/24/2015
                         release Tablets                       Development, LLC
453   IOPIDINE           Ophthalmic        0.5%                Alcon Research, Ltd.     08/2009
                         Solution
454   ISOPTO CARPINE     Ophthalmic        4%                  Novartis Pharmaceuticals 02/21/1996
                         Solution                              Corporation
                                                                                          Date Authorized
      Proprietary Name    Dosage Form             Strength    NDA Applicant Name               Generic
                                                                                        Entered the Market
455   ISOPTO CARPINE     Ophthalmic     2%                   Novartis Pharmaceuticals 02/21/1996
                         Solution                            Corporation
456   ISOPTO CARPINE     Ophthalmic     1%                   Novartis Pharmaceuticals 02/21/1996
                         Solution                            Corporation
457   JALYN              Capsules       0.5 mg/0.4 mg        GlaxoSmithKline LLC      07/2016
458   KADIAN             Extended-      60 mg                Allergan Sales, LLC      7/2012 - 7/2013
                         release
                         Capsules
459   KADIAN             Extended-      80 mg                Allergan Sales, LLC     7/2012 - 7/2013
                         release
                         Capsules
460   KADIAN             Extended-      10 mg                Allergan Sales, LLC     11/11/2011
                         release
                         Capsules
461   KADIAN             Extended-      100 mg               Allergan Sales, LLC     11/11/2011
                         release
                         Capsules
462   KADIAN             Extended-      100 mg               Allergan Sales, LLC     7/2012 - 7/2013
                         release
                         Capsules
463   KADIAN             Extended-      30 mg                Allergan Sales, LLC     7/2012 - 7/2013
                         release
                         Capsules
464   KADIAN             Extended-      20 mg                Allergan Sales, LLC     7/2012 - 7/2013
                         release
                         Capsules
                                                                                           Date Authorized
      Proprietary Name    Dosage Form               Strength    NDA Applicant Name              Generic
                                                                                         Entered the Market
465   KADIAN             Extended-         50 mg               Allergan Sales, LLC     7/2012 - 7/2013
                         release
                         Capsules
466   KADIAN             Extended-         50 mg               Allergan Sales, LLC     11/11/2011
                         release
                         Capsules
467   KADIAN             Extended-         60 mg               Allergan Sales, LLC     11/11/2011
                         release
                         Capsules
468   KADIAN             Extended-         80 mg               Allergan Sales, LLC     11/11/2011
                         release
                         Capsules
469   KADIAN             Extended-         20 mg               Allergan Sales, LLC.    11/11/2011
                         release
                         Capsules
470   KADIAN             Extended-         200 mg              Allergan Sales, LLC     11/11/2011
                         release
                         Capsules
471   KADIAN             Extended-         30 mg               Allergan Sales, LLC     11/11/2011
                         release
                         Capsules
472   KAPVAY             Extended-         0.1 mg              Concordia               06/2016
                         release Tablets                       Pharmaceuticals, Inc.
473   KAZANO             Tablets           12.5 mg/500 mg      Takeda U.S.A. Inc.      04/2016
474   KAZANO             Tablets           12.5 mg/1000 mg     Takeda U.S.A. Inc.      04/2016
475   K-DUR 10           Extended-         10 mEq              Schering Corporation    06/2002 - 06/2003
                         release Tablets
                                                                                               Date Authorized
      Proprietary Name    Dosage Form                Strength     NDA Applicant Name               Generic
                                                                                             Entered the Market
476   K-DUR 20           Extended-         20 mEq                Schering Corporation      06/1998 - 06/1999
                         release Tablets
477   KEFLEX             Capsules          750 mg                Pragma Pharmaceuticals,   06/2017
                                                                 LLC
478   KHEDEZLA           Extended-         100 mg                Osmotica Pharmaceutical   07/10/2013
                         release Tablets                         US LLC
479   KHEDEZLA           Extended-         50 mg                 Osmotica Pharmaceutical   07/10/2013
                         release Tablets                         Corporation
480   KITABIS PAK        Inhalation        300 mg/5 mL ampules   Pulmoflow Inc.            07/2016
                         Solution
481   KLARON             Lotion            10%                   Valeant Pharmaceuticals   12/2005 - 12/2006
                                                                 North America, LLC
482   K-TAB              Extended-         600 mg                AbbVie Inc.               02/2011
                         release Tablets
483   K-TAB              Extended-         750 mg                AbbVie Inc.               02/2011
                         release Tablets
484   K-TAB              Extended-         1500 mg               AbbVie Inc.               01/2014
                         release Tablets
485   LAC-HYDRIN         Cream             eq. 12% base          Bristol-Myers Squibb      07/2004 - 06/2005
                                                                 Company
486   LAC-HYDRIN         Lotion            eq. 12% base          Bristol-Myers Squibb      03/2004 - 02/2005
                                                                 Company
487   LANOXIN            Tablets           250 mcg (0.25 mg)     Concordia                 01/14/2014
                                                                 Pharmaceuticals Inc.
488   LANOXIN            Tablets           125 mcg (0.125 mg)    Concordia                 01/14/2014
                                                                 Pharmaceuticals Inc.
                                                                                             Date Authorized
      Proprietary Name    Dosage Form                Strength    NDA Applicant Name              Generic
                                                                                           Entered the Market
489   LESCOL XL          Extended-         80 mg                Novartis Pharmaceuticals 10/15/2015
                         release Tablets                        Corporation
490   LEVO-T             Tablets           75 mcg               CEDIPROF, Inc.           03/2002
491   LEVO-T             Tablets           112 mcg              CEDIPROF, Inc.           03/2002
492   LEVO-T             Tablets           125 mcg              CEDIPROF, Inc.           03/2002
493   LEVO-T             Tablets           25 mcg               CEDIPROF, Inc.           03/2002
494   LEVO-T             Tablets           88 mcg               CEDIPROF, Inc.           03/2002
495   LEVO-T             Tablets           175 mcg              CEDIPROF, Inc.           03/2002
496   LEVO-T             Tablets           150 mcg              CEDIPROF, Inc.           03/2002
497   LEVO-T             Tablets           200 mcg              CEDIPROF, Inc.           03/2002
498   LEVO-T             Tablets           300 mcg              CEDIPROF, Inc.           03/2002
499   LEVO-T             Tablets           137 mcg              CEDIPROF, Inc.           03/2002
500   LEVO-T             Tablets           50 mcg               CEDIPROF, Inc.           03/2002
501   LEVO-T             Tablets           100 mcg              CEDIPROF, Inc.           03/2002
502   LEXAPRO            Oral Solution     5 mg / 5 mL          Allergan Sales, LLC      03/26/2015
503   LEXAPRO            Tablets           20 mg                Forest Laboratories, LLC 2/29/2012
504   LEXAPRO            Tablets           5 mg                 Forest Laboratories,LLC 2/29/2012
505   LEXAPRO            Tablets           10 mg                Forest Laboratories, LLC 2/29/2012
506   LIALDA             Delayed Release   1.2 g                Shire Development LLC 08/2017
                         Tablets
507   LIBRAX             Capsules          5 mg/2.5 mg          Valeant Pharmaceuticals   09/23/2009
                                                                North America LLC
508   LIBRAX             Capsules          5 mg/2.5 mg          Valeant Pharmaceuticals   09/2016 - 08/2017
                                                                North America LLC
                                                                                                           Date Authorized
       Proprietary Name    Dosage Form                  Strength            NDA Applicant Name                 Generic
                                                                                                         Entered the Market
509   LIDEX               Topical           0.05%                          County Line                 03/2018
                          Solution                                         Pharmaceuticals, LLC
510   LIDEX               Topical           0.05%                          County Line                 04/01/2014 - 03/31/2015
                          Solution                                         Pharmaceuticals, LLC
511   LIDODERM            Patch             700 mg (50 mg per gram         Teikoku Pharma USA,         05/2014
                                            adhesive) in an aqueous base   Inc.
512   LIMBITROL           Tablets           5 mg; eq. 12.5 mg base         Valeant Pharmaceuticals     01/2006 - 12/2006
                                                                           International
513   LIMBITROL DS        Tablets           10 mg; eq. 25 mg base          Valeant Pharmaceuticals     01/2007 - 12/2007
                                                                           International
514   LIORESAL            Injection         0.5 mg/mL                      Medtronic Inc               06/1999 - 05/2000
515   LIORESAL            Injection         2 mg/mL                        Medtronic Inc               06/1999 - 05/2000
516   LIPITOR             Tablets           40 mg                          Pfizer                      1/28/2013
517   LIPITOR             Tablets           20 mg                          Pfizer                      1/28/2013
518   LIPITOR             Tablets           80 mg                          Pfizer                      1/28/2013
519   LIPITOR             Tablets           10 mg                          Pfizer                      1/28/2013
520   LIPOFEN             Capsules          150 mg                         Cipher Pharmaceuticals,     04/2016
                                                                           Inc.
521   LIPOFEN             Capsules          50 mg                          Cipher Pharmaceuticals,     04/2016
                                                                           Inc.
522   LITHOBID            Extended-         300 mg                         ANI Pharmaceuticals, Inc.   12/2016
                          release Tablets
523   LOCOID              Cream             0.1%                           Precision Dermatology,      07/2013
                                                                           Inc.
524   LOCOID (Ointment)   Ointment          0.1%                           Precision Dermatology,      10/2013 - 10/2014
                                                                           Inc.
                                                                                             Date Authorized
       Proprietary Name    Dosage Form             Strength    NDA Applicant Name                Generic
                                                                                           Entered the Market
525   LOCOID (Ointment)   Ointment       0.1%                 Precision Dermatology,     10/2015 - 10/2016
                                                              Inc.
526   LOCOID (Solution)Topical           0.1%                 Precision Dermatology,     02/1987
                       Solution                               Inc.
527   LOCOID LIPOCREAM Cream             0.1%                 Precision Dermatology,     08/22/2013
                                                              Inc
528   LOCOID LIPOCREAM    Cream          0.1%                 Precision Dermatology,     07/03/2013
                                                              Inc.
529   LODOSYN             Tablets        25 mg                Aton Pharma, Inc.          04/2014
530   LOESTRIN 24 Fe Fe   Tablets        1 mg/20 mcg          Allergan Pharmaceuticals   11/05/2015
                                                              International Ltd.
531   LOMOTIL             Tablet         2.5 mg/0.025 mg      GD Searle                  07/2011, 02/2013
532   LOPRESSOR HCT       Tablets        1 mg/mL              Novartis Pharmaceuticals   03/1998 - 03/1999
                                                              Corporation
533   LOPRESSOR HCT       Tablets        50mg / 25mg          Novartis Pharmaceuticals   11/25/2009
                                                              Corporation
534   LOPRESSOR HCT       Tablets        100 mg / 25 mg       Novartis Pharmaceuticals   11/25/2009
                                                              Corporation
535   LOPROX              Cream          0.77%                Medicis Pharmaceutical     12/2004 - 11/2005
                                                              Corporation
536   LOPROX              Gel            0.77%                County Line                07/2007 - 06/2008
                                                              Pharmaceuticals, LLC
537   LOPROX              Shampoo        1%                   Medicis Pharmaceutical     12/2012
                                                              Corporation
538   LOPROX              Topical        0.77%                Medicis Pharmaceutical     12/2003 - 11/2004
                          Suspension                          Corporation
                                                                                                    Date Authorized
      Proprietary Name    Dosage Form              Strength           NDA Applicant Name                Generic
                                                                                                  Entered the Market
539   LoSEASONIQUE       Tablets        0.1 mg/0.02 mg and 0.01 mg   Teva Branded               12/07/2010
                                                                     Pharmaceutical Products
540   LOTENSIN HCT       Tablets        10 mg; 12.5 mg               Validus Pharmaceuticals    06/2013 - 05/2014
                                                                     LLC
541   LOTENSIN HCT       Tablets        20 mg; 12.5 mg               Validus Pharmaceuticals    06/2013 - 05/2014
                                                                     LLC
542   LOTENSIN HCT       Tablets        20 mg; 25 mg                 Validus Pharmaceuticals    06/2013 - 05/2014
                                                                     LLC
543   LOTORNEX           Tablets        0.5 mg                       Sebela Ireland Limited     05/2015
544   LOTRIMIN AF        Cream          1%                           Schering-Plough            03/1998 - 03/1999
                                                                     HealthCare Products, Inc
545   LOTRISONE          Cream          1%/0.05%                     Merck Sharp & Dohme        8/16/2012
                                                                     Corporation
546   LOTRONEX           Tablets        1 mg                         Sebela Ireland Limited     05/2015
547   LOVAZA             Capsules       1 gram                       GlaxoSmithKline LLC        03/05/2015
548   LOVENOX            Injection      60 mg/0.6 mL                 Sanofi Aventis US LLC      10/2011
549   LOVENOX            Injection      30 mg/0.3 mL                 Sanofi Aventis US LLC      10/2011
550   LOVENOX            Injection      300 mg/3mL                   Sanofi Aventis US LLC      10/2011
551   LOVENOX            Injection      150 mg/1 mL                  Sanofi Aventis US LLC      10/2011
552   LOVENOX            Injection      120 mg/0.8 mL                Sanofi Aventis US LLC      10/2011
553   LOVENOX            Injection      30 mg prefilled syringe      Sanofi Aventis US LLC      03/2015
554   LOVENOX            Injection      80 mg/0.8 mL                 Sanofi Aventis US LLC      10/2011
555   LOVENOX            Injection      40 mg/0.4 mL                 Sanofi Aventis US LLC      10/2011
556   LOVENOX            Injection      80 mg prefilled syringe      Sanofi Aventis US LLC      03/2015
557   LOVENOX            Injection      120 mg prefilled syringe     Sanofi Aventis US LLC      05/2015
                                                                                                   Date Authorized
      Proprietary Name    Dosage Form              Strength         NDA Applicant Name                   Generic
                                                                                                 Entered the Market
558   LOVENOX            Injection      150 mg prefilled syringe   Sanofi Aventis US LLC       05/2015
559   LOVENOX            Injection      100 mg prefilled syringe   Sanofi Aventis US LLC       03/2015
560   LOVENOX            Injection      40 mg prefilled syringe    Sanofi Aventis US LLC       03/2015
561   LOVENOX            Injection      60 mg prefilled syringe    Sanofi Aventis US LLC       03/2015
562   LOVENOX            Injection      100 mg/1 mL                Sanofi Aventis US LLC       10/2011
563   LOVENOX            Injection      300 mg prefilled syringe   Sanofi Aventis US LLC       03/2015
564   LOZOL              Tablets        2.5 mg                     Rhone-Poulenc Rorer         Prior to 1/1/1999
                                                                   Pharmaceuticals Inc.
565   LUVOX              Tablets        50 mg                      ANI Pharmaceuticals, Inc.   08/09/2011
566   LUVOX              Tablets        25 mg                      ANI Pharmaceuticals, Inc.   08/09/2011
567   LUVOX              Tablets        100 mg                     ANI Pharmaceuticals, Inc.   08/09/2011
568   LYSTEDA            Tablets        650 mg                     Ferring Pharmaceuticals     03/17/2016
                                                                   Inc.
569   LYSTEDA            Tablets        650 mg                     Ferring Pharmaceuticals     01/03/2013
                                                                   Inc.
570   MACROBID           Capsules       100 mg                     Alvogen PB Research and     02/2011
                                                                   Development, LLC
571   MACROBID           Capsules       100 mg                     Alvogen PB Research and     02/2011
                                                                   Development, LLC
572   MACRODANTIN        Capsules       50 mg                      Alvogen PB Research and     08/2011
                                                                   Development, LLC
573   MACRODANTIN        Capsules       50 mg                      Alvogen PB Research and     08/2011
                                                                   Development, LLC
574   MACRODANTIN        Capsules       100 mg                     Alvogen PB Research and     08/2011
                                                                   Development, LLC
                                                                                                   Date Authorized
      Proprietary Name    Dosage Form              Strength            NDA Applicant Name              Generic
                                                                                                 Entered the Market
575   MACRODANTIN        Capsules       100 mg                        Alvogen PB Research and 08/2011
                                                                      Development, LLC
576   MACRODANTIN        Capsules       25 mg                         Alvogen PB Research and 09/2010
                                                                      Development, LLC
577   MALARONE           Tablets        250 mg/100 mg                 GlaxoSmithKline LLC      7/31/2012
578   MARINOL            Capsules       2.5 mg                        AbbVie                   05/2008 - 05/2009
579   MARINOL            Capsules       5 mg                          AbbVie                   05/2008 - 05/2009
580   MARINOL            Capsules       10 mg                         AbbVie                   05/2008 - 05/2009
581   MAXITROL           Ophthalmic     3.5 mg, 10000 units, 0.1% /   Alcon Laboratories, Inc. 03/04/1996
                         Ointment       gram
582   MAXZIDE            Tablets        75 mg and 50 mg               Mylan Pharmaceuticals     Prior to 1/1/1999
                                                                      Inc.
583   MAXZIDE-25         Tablets        37.5 mg and 25 mg             Mylan Pharmaceuticals     Prior to 1/1/1999
                                                                      Inc.
584   MEDROL             Tablets        4 mg                          Pharmacia and Upjohn      11/16/2011
585   MEDROL             Tablets        32 mg                         Pharmacia and Upjohn      4/22/2013
586   MEDROL             Tablets        16 mg                         Pharmacia and Upjohn      4/22/2013
587   MEDROL             Tablets        8 mg                          Pharmacia and Upjohn      4/22/2013
588   MEPRON             Suspension     750 mg/5mL                    GlaxoSmithKline LLC       03/20/2014
589   MESNEX             Injection      100 mg/mL                     Baxter Healthcare         12/2003 - 12/2004
                                                                      Corporation
590   MESTINON           Tablets        60 mg                         Valeant Pharmaceuticals   04/2002 - 03/2003
                                                                      North America, LLC
591   MESTINON           Tablets        180 mg                        Valeant Pharmaceuticals   11/2015
      TIMESPAN                                                        North America, LLC
                                                                                          Date Authorized
      Proprietary Name    Dosage Form             Strength    NDA Applicant Name              Generic
                                                                                        Entered the Market
592   METADATE CD        Extended-       10 mg               Lannett Company, Inc.    09/2012
                         release
                         Capsules
593   METADATE CD        Extended-       30 mg               Lannett Company, Inc.    09/2012
                         release
                         Capsules
594   METADATE CD        Extended-       60 mg               Lannett Company, Inc.    09/2012
                         release
                         Capsules
595   METADATE CD        Extended-       50 mg               Lannett Company, Inc.    09/2012
                         release
                         Capsules
596   METADATE CD        Extended-       40 mg               Lannett Company, Inc.    09/2012
                         release
                         Capsules
597   METADATE CD        Extended-       20 mg               Lannett Company, Inc.    09/2012
                         release
                         Capsules
598   METHYLIN           Oral Solution   10 mg/5 mL          Mallinckrodt Inc.        08/01/2013
599   METHYLIN           Oral Solution   5 mg/5 mL           Mallinckrodt Inc.        08/01/2013
600   METROCREAM         Cream           0.75%               Galderma Laboratories,   03/2015
                                                             L.P.
601   METROCREAM         Cream           0.75%               Galderma Laboratories,   3/2009
                                                             L.P.
602   METROGEL           Gel             1%                  Galderma Laboratories,   02/2017
                                                             L.P.
                                                                                                Date Authorized
      Proprietary Name    Dosage Form              Strength       NDA Applicant Name                Generic
                                                                                              Entered the Market
603   METROGEL           Gel            0.75%                    Galderma Laboratories,     03/2014
                                                                 L.P.
604   METROGEL           Gel            0.75%                    Galderma Laboratories,     03/2014
                                                                 L.P.
605   METROGEL           Gel            1%                       Galderma Laboratories,     06/2005
                                                                 L.P.
606   METROGEL-          Vaginal Gel    0.75%                    Medicis Pharmaceuticals,   04/01/2015
      VAGINAL                                                    a Div. Of Valeant
                                                                 Pharmaceuticals North
                                                                 America LLC
607   METROLOTION        Lotion         0.75%                    Galderma Laboratories,     6/16/2009
                                                                 L.P.
608   MIACALCIN          Nasal Spray    200 I.U. per actuation   Sebela Ireland Ltd.        12/09/2008
609   MICARDIS           Tablets        40 mg                    Boehringer Ingelheim       11/13/2013
                                                                 Pharmaceuticals, Inc.
610   MICARDIS           Tablets        80 mg                    Boehringer Ingelheim       11/13/2013
                                                                 Pharmaceuticals, Inc.
611   MICARDIS           Tablets        20 mg                    Boehringer Ingelheim       11/13/2013
                                                                 Pharmaceuticals, Inc.
612   MICARDIS HCT       Tablets        80 mg/12.5 mg            Boehringer Ingelheim       02/28/2014
                                                                 Pharmaceuticals, Inc.
613   MICARDIS HCT       Tablets        80 mg/25 mg              Boehringer Ingelheim       02/28/2014
                                                                 Pharmaceuticals, Inc.
614   MICARDIS HCT       Tablets        40 mg/12.5 mg            Boehringer Ingelheim       02/28/2014
                                                                 Pharmaceuticals, Inc.
                                                                                           Date Authorized
      Proprietary Name    Dosage Form             Strength    NDA Applicant Name               Generic
                                                                                         Entered the Market
615   MICRO-K            Extended-      8 mEq (600 mg)       Nesher Pharmaceuticals    03/10/2011
      EXTENCAPS          Release                             USA LLC
                         Capsules
616   MICRO-K            Extended-      10 mEq (750 mg)      Nesher Pharmaceuticals    01/19/2011
      EXTENCAPS          Release                             USA LLC
                         Capsules
617   MICRONASE          Tablets        2.5 mg               Pharmacia and Upjohn      Prior to 1/1/1999
618   MICRONASE          Tablets        5 mg                 Pharmacia and Upjohn      Prior to 1/1/1999
619   MICROZIDE          Capsules       12.5 mg              Allergan Sales, LLC       10/05/2001
620   MIDAMOR            Tablets        5 mg                 Paddock Laboratories      04/06/2009
621   MIGRANAL           Nasal Spray    4 mg in 1 mL         Valeant Pharmaceuticals   03/18/2013
                                                             North America, LLC
622   MINIPRESS          Capsules       1 mg                 Pfizer Inc.               01/2017
623   MINIPRESS          Capsules       2 mg                 Pfizer Inc.               01/2017
624   MINIPRESS          Capsules       5 mg                 Pfizer Inc.               01/2017
625   MITIGARE           Capsules       0.6 mg               Hikma International       10/01/2014
                                                             Pharmaceuticals LLC
626   MOBIC              Oral           7.5 mg/5 mL          Boehringer Ingelheim      6/12/2006
                         Suspension                          Pharmaceuticals Inc.
627   MONODOX            Capsules       75 mg                Aqua Pharmaceuticals      10/2014
                                                             LLC
628   MONODOX            Capsules       50 mg                Aqua Pharmaceuticals      02/07/2005
                                                             LLC
629   MONODOX            Capsules       100 mg               Aqua Pharmaceuticals      02/07/2005
                                                             LLC
                                                                                                         Date Authorized
      Proprietary Name    Dosage Form                Strength              NDA Applicant Name                Generic
                                                                                                       Entered the Market
630   MONOKET            Tablets           10 mg                          Kremers Urban              06/30/1996 - 06/29/1997
                                                                          Pharmaceuticals, Inc.
631   MONOKET            Tablets           20 mg                          Kremers Urban              06/30/1996 - 06/29/1997
                                                                          Pharmaceuticals, Inc.
632   MOXATAG            Extended-         775 mg                         Vernalis (R&D) Limited     08/20/2014
                         Release Tablets
633   MS CONTIN          Extended-         15 mg                          Purdue Pharma L.P.         05/2005 - 05/2006
                         release Tablets
634   MS CONTIN          Extended-         30 mg                          Purdue Pharma L.P.         05/2005 - 05/2006
                         release Tablets
635   MS CONTIN          Extended-         60 mg                          Purdue Pharma L.P.         05/2005 - 05/2006
                         release Tablets
636   MS CONTIN          Extended-         100 mg                         Purdue Pharma L.P.         05/2005 - 05/2006
                         release Tablets
637   MS CONTIN          Extended-         200 mg                         Purdue Pharma L.P.         05/2005 - 05/2006
                         release Tablets
638   MYAMBUTOL          Tablets           100 mg                         STI Pharma LLC             12/15/2006
639   MYAMBUTOL          Tablets           400 mg                         STI Pharma LLC             12/15/2006
640   MYCOBUTIN          Capsules          150 mg                         Pharmacia and Upjohn       05/13/2014
                                                                          Company
641   NAFTIN CREAM       Cream             2%                             Sebela Ireland Ltd         06/01/2015
                         emulsion
642   NAFTIN CREAM       Cream             1%                             Sebela Ireland Ltd         06/01/2015
                         emulsion
643   NALFON             Capsules          400 mg                         Xsprire Pharma             08/05/2015
644   NAMENDA            Tablets           5 mg and 10 mg (titration pak) Forest Laboratories, LLC   04/01/2015
                                                                                              Date Authorized
      Proprietary Name    Dosage Form                 Strength    NDA Applicant Name              Generic
                                                                                            Entered the Market
645   NAMENDA            Tablets           5 mg                  Forest Laboratories, LLC 04/01/2015
646   NAMENDA            Tablets           10 mg                 Forest Laboratories, LLC 04/01/2015
647   NAPRELAN           Controlled-       500 mg                Alvogen PB Research and 03/2015
                         Release Tablets                         Development LLC
648   NAPRELAN           Controlled-       375 mg                Alvogen PB Research and 09/2015
                         Release Tablets                         Development LLC
649   NARDIL             Tablet            15 mg                 Parke-Davis              3/23/2011
650   NASACORT AQ        Nasal Spray       55 mcg/spray          Sanofi Aventis US, LLC 06/15/2011
                         Spray Bottle
651   NASONEX            Suspension        50 mcg                Merck Sharp & Dohme       03/25/2016
                                                                 Corporation
652   NATROBA            Topical           0.9%                  ParaPRO LLC               06/2014
                         Suspension
653   NEOPROFEN          Injection         10 mg/mL              Recordati Rare Diseases   04/2016
                                                                 Inc.
654   NESINA             Tablets           12.5 mg               Takeda U.S.A. Inc.        04/2016
655   NESINA             Tablets           25 mg                 Takeda U.S.A. Inc.        04/2016
656   NESINA             Tablets           6.25 mg               Takeda U.S.A. Inc.        04/2016
657   NEURONTIN          Capsules          100 mg                Pfizer Inc.               3/17/2004
658   NEURONTIN          Capsules          300 mg                Pfizer Inc.               03/17/2004
659   NEURONTIN          Capsules          400 mg                Pfizer Inc.               3/17/2004
660   NEURONTIN          Oral Solution     250 mg per 5 mL       Pfizer Inc.               3/24/2011
661   NEURONTIN          Tablets           600 mg                Pfizer Inc.               3/17/2004
662   NIASPAN            Extended-         500 mg                AbbVie                    06/30/2014
                         release Tablets
                                                                                               Date Authorized
      Proprietary Name    Dosage Form                Strength    NDA Applicant Name                Generic
                                                                                             Entered the Market
663   NIASPAN            Extended-         750 mg               AbbVie                     06/30/2014
                         release Tablets
664   NIASPAN            Extended-         1000 mg              AbbVie                     06/30/2014
                         release Tablets
665   NICORETTE          Chewing Gum       2 mg                 GlaxoSmithKline            01/2002 - 01/2003
                                                                Consumer Healthcare L.P.
666   NICORETTE          Chewing Gum       4 mg                 GlaxoSmithKline            06/2001 - 06/2002
                                                                Consumer Healthcare L.P.
667   NITROLINGUAL       Lingual Spray     400 mcg per Spray    G. Pohl-Boskamp GmbH       02/01/2011
      PUMPSPRAY                                                 & Co. Arbor
                                                                Pharmaceuticals
668   NITROMIST          Lingual Aerosol 400 mcg/spray          Mist Pharmaceuticals,      10/16/2012
                                                                LLC
669   NITROSTAT          Tablets           0.4 mg               Pfizer Pharmaceuticals     08/26/2016
                                                                Ltd.
670   NITROSTAT          Tablets           0.6 mg               Pfizer Pharmaceuticals     08/26/2016
                                                                Ltd.
671   NITROSTAT          Tablets           0.3 mg               Pfizer Pharmaceuticals     08/26/2016
                                                                Ltd.
672   NIZORAL            Shampoo           2%                   Janssen Research &         08/10/2005
                                                                Development, LLC
673   NORFLEX            Extended-         100 mg               3M Pharmaceuticals         Prior to 1/1/1999
                         release Tablets
674   NORINYL            Tablets           1.0 mg / 0.05 mg     Actavis Laboratories UT,   02/22/2007
                                                                Inc.
675   NORPRAMIN          Tablets           150 mg               Sanofi-Aventis US LLC      04/2014
                                                                                                          Date Authorized
      Proprietary Name    Dosage Form                Strength               NDA Applicant Name                  Generic
                                                                                                        Entered the Market
676   NORPRAMIN          Tablets          10 mg                            Sanofi-Aventis US LLC      04/2014
677   NORPRAMIN          Tablets          25 mg                            Sanofi-Aventis US LLC      04/2014
678   NORPRAMIN          Tablets          50 mg                            Sanofi-Aventis US LLC      Prior to 1/1/1999
679   NORPRAMIN          Tablets          75 mg                            Sanofi-Aventis US LLC      04/2014
680   NORPRAMIN          Tablets          100 mg                           Sanofi-Aventis US LLC      04/2014
681   NOR-QD             Tablets          0.35 mg                          Actavis Laboratories UT,   06/06/2003
                                                                           Inc.
682   NORVASC            Tablets          2.5 mg                           Pfizer Inc.                4/16/2007; 6/15/2006
683   NORVASC            Tablets          5 mg                             Pfizer Inc.                4/16/2007; 6/15/2006
684   NORVASC            Tablets          10 mg                            Pfizer Inc.                4/16/2007; 6/15/2006
685   NULYTELY           Powder (for      Per 4 liter jug: polyethylene    Braintree Laboratories,    02/2013
                         reconstitution   glycol 3350 420 g, sodium        Inc.Y
                         with water)      bicarbonate 5.72 g, sodium
                                          chloride 11.2 g, potassium
                                          chloride 1.48 g, flavoring 2 g
686   OCUFEN             Ophthalmic       0.03 %                           Allergan, Inc              05/2007
                         Solution
687   OLUX               Foam             0.05%                            Mylan Pharmaceuticals      02/2014
                                                                           Inc.
688   OLUX-E             Emulsion,        0.05%                            Mylan Pharmaceuticals      01/2014
                         Aerosol Foam                                      Inc.
689   OMNIPRED           Ophthalmic       1%                               Alcon Pharmaceuticals      01/1995
                         Suspension                                        Ltd. / Alcon Research
                                                                           Ltd.
690   OPANA              Tablets          5 mg                             Endo Pharmaceuticals,      09/29/2010
                                                                           Inc.
                                                                                                     Date Authorized
      Proprietary Name    Dosage Form               Strength             NDA Applicant Name              Generic
                                                                                                   Entered the Market
691   OPANA              Tablets          10 mg                         Endo Pharmaceuticals,    09/29/2010
                                                                        Inc.
692   OPTIVAR            Ophthalmic       0.05%                         Meda Pharmaceuticals,    03/10/2011
                         Solution                                       Inc.
693   ORABLOC            Injection        4% and 1:100,000              Pierrel S.p.A.           10/2016
694   ORABLOC            Injection        4% and 1:200,000              Pierrel S.p.A.           10/2016
695   ORACEA             Capsules         40 mg                         Galderma Laboratories,   04/2015
                                                                        L.P.
696   ORAPRED ODT        Orally           10 mg                         Concordia                10/2015
                         Disintegrating                                 Pharmaceuticals Inc.
                         Tablets
697   ORAPRED ODT        Orally           30 mg                         Concordia                10/2015
                         Disintegrating                                 Pharmaceuticals Inc.
                         Tablets
698   ORAPRED ODT        Orally           15 mg                         Concordia                10/2015
                         Disintegrating                                 Pharmaceuticals Inc.
                         Tablets
699   ORTHO CYCLEN-28    Tablets          0.25/0.035 mg                 Janssen Research &       01/2003
                                                                        Development, LLC
700   ORTHO MICRONOR     Tablets          0.35 mg                       Janssen Research and     06/2003
                                                                        Development LLC
701   ORTHO TRI-CYCLEN   Tablets          0.180/0.035 mg; 0.215/0.035   Janssen Research and     9/2003
                                          mg; 0.250/0.035 mg            Development, LLC
702   ORTHO TRI-CYCLEN   Tablets          0.180/0.025 mg; 0.215/0.025   Janssen Research and     01/04/2016
      LO                                  mg; 0.250/0.025 mg            Development, LLC
                                                                                                 Date Authorized
      Proprietary Name     Dosage Form                Strength     NDA Applicant Name                Generic
                                                                                               Entered the Market
703   ORTHO-NOVUM 7/7/7   Tablets           0.5 mg and 0.035 mg   Janssen Research &         11/11/2002
                                                                  Development, LLC
704   OSENI               Tablets           25 mg/15 mg           Takeda U.S.A. Inc.         04/2016
705   OSENI               Tablets           12.5 mg/15 mg         Takeda U.S.A. Inc.         04/2016
706   OSENI               Tablets           12.5 mg/30 mg         Takeda U.S.A. Inc.         04/2016
707   OSENI               Tablets           12.5 mg/45 mg         Takeda U.S.A. Inc.         04/2016
708   OSENI               Tablets           25 mg/30 mg           Takeda U.S.A. Inc.         04/2016
709   OSENI               Tablets           25 mg/45 mg           Takeda U.S.A. Inc.         04/2016
710   OVIDE               Lotion            0.5%                  Taro Pharmaceuticals       08/02/2008 - 08/01/2009
                                                                  USA, Inc.
711   OXANDRIN            Tablets           2.5 mg                Savient Pharmaceuticals,   06/2006 - 05/2007
                                                                  Inc.
712   OXANDRIN            Tablets           10 mg                 Savient Pharmaceuticals,   06/2006 - 05/2007
                                                                  Inc.
713   OXSORALEN ULTRA     Capsule           10 mg                 Dow Pharmaceutical         07/15/2014
                                                                  Sciences
714   OXYCODONE           Capsules          5 mg                  Genus Lifesciences, Inc.   12/15/2010
      HYDROCHLORIDE
715   OXYCODONE           Oral Solution     100 mg/5 mL           Genus Lifesciences, Inc.   12/20/2010
      HYDROCHLORIDE
716   OXYCONTIN           Extended-         80 mg                 Purdue Pharma              03/24/2015
                          release Tablets
717   OXYCONTIN           Extended-         80 mg                 Purdue Pharma              09/22/2014
                          release Tablets
718   OXYCONTIN           Extended-         40 mg                 Purdue Pharma              09/22/2014
                          release Tablets
                                                                                        Date Authorized
      Proprietary Name    Dosage Form              Strength    NDA Applicant Name           Generic
                                                                                      Entered the Market
719   OXYCONTIN          Extended-         40 mg              Purdue Pharma         08/28/2014
                         release Tablets
720   OXYCONTIN          Extended-         40 mg              Purdue Pharma         09/22/2014
                         release Tablets
721   OXYCONTIN          Extended-         40 mg              Purdue Pharma         03/24/2015
                         release Tablets
722   OXYCONTIN          Extended-         40 mg              Purdue Pharma         08/14/2014
                         release Tablets
723   OXYCONTIN          Extended-         15 mg              Purdue Pharma         03/2016
                         release Tablets
724   OXYCONTIN          Extended-         60 mg              Purdue Pharma         03/2016
                         release Tablets
725   OXYCONTIN          Extended-         30 mg              Purdue Pharma         03/2016
                         release Tablets
726   OXYCONTIN          Extended-         10 mg              Purdue Pharma         03/2016
                         release Tablets
727   OXYCONTIN          Extended-         20 mg              Purdue Pharma         03/2016
                         release Tablets
728   OXYCONTIN          Extended-         80 mg              Purdue Pharma         09/22/2014
                         release Tablets
729   OXYCONTIN          Extended-         80 mg              Purdue Pharma         03/2016
                         release Tablets
730   OXYCONTIN          Extended-         40 mg              Purdue Pharma         03/2016
                         release Tablets
731   OXYCONTIN          Extended-         80 mg              Purdue Pharma         08/14/2014
                         release Tablets
                                                                                                  Date Authorized
      Proprietary Name    Dosage Form                   Strength         NDA Applicant Name           Generic
                                                                                                Entered the Market
732   OXYCONTIN          Extended-         80 mg                       Purdue Pharma          08/14/2014
                         release Tablets
733   OXYCONTIN          Extended-         20 mg                       Purdue Pharma          08/28/2014
                         release Tablets
734   OXYCONTIN          Extended-         10 mg                       Purdue Pharma          10/08/2014
                         release Tablets
735   OXYCONTIN          Extended-         20 mg                       Purdue Pharma          03/24/2015
                         release Tablets
736   OXYCONTIN          Extended-         10 mg                       Purdue Pharma          03/24/2015
                         release Tablets
737   OXYCONTIN          Extended-         20 mg                       Purdue Pharma          09/29/2014
                         release Tablets
738   OXYCONTIN          Extended-         10 mg                       Purdue Pharma          08/14/2014
                         release Tablets
739   PARAPLATIN         for Injection     50 mg/vial                  Bristol-Myers Squibb   03/2004 - 02/2005
                                                                       Company
740   PARAPLATIN         for Injection     150 mg/vial                 Bristol-Myers Squibb   03/2004 - 02/2005
                                                                       Company
741   PARAPLATIN         for Injection     450 mg/vial                 Bristol-Myers Squibb   03/2004 - 02/2005
                                                                       Company
742   PARAPLATIN AQ      Injection         eq. 50 mg/5 mL (10 mg/mL)   Bristol-Myers Squibb   07/2004 - 06/2005
                                                                       Company
743   PARAPLATIN AQ      Injection         eq. 150 mg/15 mL (10 mg/mL) Bristol-Myers Squibb   07/2004 - 06/2005
                                                                       Company
744   PARAPLATIN AQ      Injection         eq. 450 mg/45 mL (10 mg/mL) Bristol-Myers Squibb   07/2004 - 06/2005
                                                                       Company
                                                                                                    Date Authorized
      Proprietary Name    Dosage Form              Strength            NDA Applicant Name               Generic
                                                                                                  Entered the Market
745   PARAPLATIN AQ      Injection       eq. 600 mg/60 mL (10 mg/mL) Bristol-Myers Squibb       07/2004 - 06/2005
                                                                     Company
746   PARLODEL           Capsules        5 mg                        Validus Pharmaceuticals    12/1998, 4/2006
                                                                     LLC
747   PARLODEL           Tablets         2.5 mg                      Validus Pharmaceuticals    Prior to 1/1/1999
                                                                     LLC
748   PARNATE            Tablets         10 mg                       Concordia                  02/05/2016
                                                                     Pharmaceuticals Inc.
749   PATADAY            Ophthalmic      0.2%                        Novartis Pharmaceuticals   06/2017
                         Solution                                    Corporation
750   PATANASE           Nasal Spray     665 mcg in 100 mg solution  Novartis Pharmaceuticals   04/2015
                                                                     Corporation
751   PATANASE           Nasal Spray     665 mcg in 100 mg solution  Novartis Pharmaceuticals   04/2015
                                                                     Corporation
752   PATANOL            Ophthalmic      0.1%                        Novartis Pharmaceuticals   09/15/2015
                         Solution                                    Corporation
753   PAXIL CR           Tablets         12.5 mg                     GlaxoSmithKline            10/21/2010
754   PAXIL CR           Tablets         25 mg                       GlaxoSmithKline            10/21/2010
755   PAXIL CR           Tablets         37.5 mg                     GlaxoSmithKline            10/21/2010
756   PEDIAPRED          Oral Solution   eq. 5 mg base/5 mL          UCB, Inc.                  11 Feb 2002
757   PHOSLO             Gelcaps         667 mg                      Fresenius Medical Care     03/2014 - 03/2015
                                                                     North America
758   PLAN B ONE STEP    Tablets         1.5 mg                      Teva Branded               02/12/2014
                                                                     Pharmaceutical Products
                                                                     R&D, Inc.
                                                                                                 Date Authorized
      Proprietary Name      Dosage Form                   Strength    NDA Applicant Name             Generic
                                                                                               Entered the Market
759   PLAQUENIL            Tablets           200 mg                  Concordia               05/1999 - 04/2000
                                                                     Pharmaceuticals Inc.
760   PLENDIL              Extended-         2.5 mg                  AstraZeneca LP          10/2008
                           release Tablets
761   PLENDIL              Extended-         5 mg                    AstraZeneca LP          10/2008
                           release Tablets
762   PLENDIL              Extended-         10 mg                   AstraZeneca LP          10/2008
                           release Tablets
763   PLETAL               Tablets           50 mg                   Otsuka Pharmaceutical   10/18/2004
                                                                     Company, Ltd.
764   PLETAL               Tablets           100 mg                  Otsuka Pharmaceutical   10/18/2004
                                                                     Company, Ltd.
765   POLYTRIM          Ophthalmic           10 mL unit              Allergan, Inc.          04/29/1997
                        Solution
766   PONSTEL           Capsules             250 mg                  Shionogi, Inc.           07/11/2011
767   POTASSIUM         Powder for           20 mEq                  Pharma Research Software 01/2017
      CHLORIDE FOR ORAL Solution                                     Solution, LLC
      SOLUTION
768   POTASSIUM            Powder for        20 mEq                  Pharma Research Software 09/2015
      CHLORIDE FOR ORAL    Solution                                  Solution, LLC
      SOLUTION
769   POTASSIUM            Oral Solution     20 mEq per 15 mL        Lehigh Valley           05/14/2015
      CHLORIDE ORAL                                                  Technologies
      SOLUTION, USP, 10%
770   POTASSIUM            Oral Solution     20 mEq per 15 mL        Lehigh Valley           05/14/2015
      CHLORIDE ORAL                                                  Technologies
      SOLUTION, USP, 10%
                                                                                                     Date Authorized
      Proprietary Name      Dosage Form                Strength           NDA Applicant Name             Generic
                                                                                                   Entered the Market
771   POTASSIUM            Oral Solution     40 mEq per 15 mL            Lehigh Valley           05/14/2015
      CHLORIDE ORAL                                                      Technologies
      SOLUTION, USP, 20%
772   PRAVACHOL            Tablets           10 mg                       Bristol-Myers Squibb    10/2005 - 09/2006
                                                                         Company
773   PRAVACHOL            Tablets           20 mg                       Bristol-Myers Squibb    10/2005 - 09/2006
                                                                         Company
774   PRAVACHOL            Tablets           40 mg                       Bristol-Myers Squibb    10/2005 - 09/2006
                                                                         Company
775   PRAVACHOL            Tablets           80 mg                       Bristol-Myers Squibb    10/2005 - 09/2006
                                                                         Company
776   PRECOSE              Tablets           25 mg                       Bayer Healthcare        01/30/2008
                                                                         Pharmaceuticals, Inc.
777   PRECOSE              Tablets           50 mg                       Bayer Healthcare        01/30/2009
                                                                         Pharmaceuticals, Inc.
778   PRECOSE              Tablets           100 mg                      Bayer Healthcare        01/30/2009
                                                                         Pharmaceuticals, Inc.
779   PRED FORTE           Ophthalmic        1%                          Allergan, Inc.          08/1997
                           Suspension
780   PREVACID             Delayed-Release   15 mg                       Takeda Global Research & 11/2009
                           Capsules                                      Development Center, Inc.
781   PREVACID             Delayed-Release   30 mg                       Takeda Global Research & 11/2009
                           Capsules                                      Development Center, Inc.
782   PREVPAC              Delayed-Release   30 mg, 500 mg, and 500 mg   Takeda Pharmaceuticals 03/02/2015
                           Capsules,                                     U.S.A., Inc.
                           Capsules, and
                           Tablets
                                                                                             Date Authorized
      Proprietary Name    Dosage Form               Strength    NDA Applicant Name               Generic
                                                                                           Entered the Market
783   PRILOSEC           Delayed-release   40 mg               AstraZeneca LP            04/2008
                         Capsules
784   PRISTIQ            Extended-         25 mg               PF Prism C.V.             03/2017
                         Release Tablets
785   PRISTIQ            Extended-         100 mg              PF Prism C.V.             03/2017
                         Release Tablets
786   PRISTIQ            Extended-         50 mg               PF Prism C.V.             03/2017
                         Release Tablets
787   PROCARDIA          Capsules          10 mg               Pfizer Inc.               3/25/2013
788   PROCARDIA XL       Extended-         90 mg               Pfizer Inc.               3/31/10 and 4/29/10
                         release Tablets
789   PROCARDIA XL       Extended-         60 mg               Pfizer Inc.               3/31/10 and 4/29/10
                         release Tablets
790   PROCARDIA XL       Extended-         30 mg               Pfizer Inc.               3/31/10 and 4/29/10
                         release Tablets
791   PROMETRIUM         Capsules          200 mg              Virtus Pharmaceuticals,   07/30/2010
                                                               LLC
792   PROMETRIUM         Capsules          100 mg              Virtus Pharmaceuticals,   07/30/2010
                                                               LLC
793   PROMETRIUM         Capsules          200 mg              Virtus Pharmaceuticals,   07/2016
                                                               LLC
794   PROMETRIUM         Capsules          100 mg              Virtus Pharmaceuticals,   07/2016
                                                               LLC
795   PROVERA            Tablets           2.5 mg              Pharmacia and Upjohn      6/18/2003
796   PROVERA            Tablets           5 mg                Pharmacia and Upjohn      6/18/2003
797   PROVERA            Tablets           10 mg               Pharmacia and Upjohn      6/18/2003
                                                                                                  Date Authorized
      Proprietary Name    Dosage Form             Strength           NDA Applicant Name               Generic
                                                                                                Entered the Market
798   PROVIGIL           Tablets        100 mg                      Cephalon, Inc.            03/29/2012
799   PROVIGIL           Tablets        200 mg                      Cephalon Inc.             03/29/2012
800   PURINETHOL         Tablets        50 mg                       Stason Pharmaceuticals    11/2016
                                                                    Inc.
801   QUALAQUIN          Capsules       324 mg                      Sun Pharmaceutical        07/23/2012
                                                                    Industries, Inc.
802   QUARTETTE          Tablets        0.15 mg/0.02 mg, 0.15       Teva Branded              04/2017
                                        mg/0.025 mg, 0.15 mg/0.03   Pharmaceutical Products
                                        mg, and 0.01 mg             R&D, Inc.
803   QUARTETTE          Tablets        0.15 mg/0.02 mg, 0.15       Teva Branded              03/2018
                                        mg/0.025 mg, 0.15 mg/0.03   Pharmaceutical Products
                                        mg, and 0.01 mg             R&D, Inc.
804   QUEDEXY XR         Extended-      150 mg                      Upsher-Smith              07/07/2014
                         release                                    Pharmaceuticals
                         Capsules
805   QUEDEXY XR         Extended-      100 mg                      Upsher-Smith              07/07/2014
                         release                                    Pharmaceuticals
                         Capsules
806   QUEDEXY XR         Extended-      200 mg                      Upsher-Smith              07/07/2014
                         release                                    Pharmaceuticals
                         Capsules
807   QUEDEXY XR         Extended-      50 mg                       Upsher-Smith              07/07/2014
                         release                                    Pharmaceuticals
                         Capsules
808   QUEDEXY XR         Extended-      25 mg                       Upsher-Smith              07/07/2014
                         release                                    Pharmaceuticals
                         Capsules
                                                                                          Date Authorized
      Proprietary Name    Dosage Form               Strength    NDA Applicant Name            Generic
                                                                                        Entered the Market
809   RAPAMUNE           Tablets          1 mg                 PF Prism CV            10/27/2014
810   RAPAMUNE           Tablets          0.5 mg               PF Prism C.V.          01/16/2014
811   RAPAMUNE           Tablets          2 mg                 PF Prism CV            10/27/2014
812   RAZADYNE           Tablets          4 mg                 Janssen Research and   08/28/2008
                                                               Development, LLC
813   RAZADYNE           Tablets          8 mg                 Janssen Research and   08/28/2008
                                                               Development, LLC
814   RAZADYNE           Tablets          12 mg                Janssen Research and   08/28/2008
                                                               Development, LLC
815   RAZADYNE ER        Capsules         8 mg                 Janssen Research and   10/13/2008
                                                               Development, LLC
816   RAZADYNE ER        Capsules         16 mg                Janssen Research and   10/13/2008
                                                               Development, LLC
817   RAZADYNE ER        Capsules         24 mg                Janssen Research and   10/13/2008
                                                               Development, LLC
818   REGLAN             Injection        eq. 5 mg base/mL     Baxter Healthcare      02/2003 - 02/2004
                                                               Corporation
819   REGLAN             Tablets          eq. 5 mg base        A.H. Robins, Inc.      08 March 2010
820   RELPAX             Tablets          40 mg                Pfizer Ireland         07/2017
                                                               Pharmaceuticals
821   RELPAX             Tablets          20 mg                Pfizer Ireland         07/2017
                                                               Pharmaceuticals
822   REMERON SOLTAB     Orally           15 mg                Organon USA, Inc.      10/06/2004
                         Disintegrating
                         Tablets
                                                                                             Date Authorized
      Proprietary Name    Dosage Form               Strength    NDA Applicant Name               Generic
                                                                                           Entered the Market
823   REMERON SOLTAB     Orally           30 mg                Organon USA, Inc.         10/06/2004
                         Disintegrating
                         Tablets
824   REMERON SOLTAB     Orally           45 mg                Organon USA, Inc.         10/06/2004
                         Disintegrating
                         Tablets
825   RENVELA            Tablets          800 mg               Genzyme Corporation       04/16/2014
826   RESTORIL           Capsules         22.5 mg              Mallinckrodt Inc.         07/21/2008
827   RESTORIL           Capsules         7.5 mg               Mallinckrodt Inc.         07/22/2008
828   RETIN-A            Cream            0.1%                 Valeant Pharmaceuticals   02/06/2014
                                                               North America, LLC
829   RETIN-A            Cream            0.05%                Valeant Pharmaceuticals   07/19/1974
                                                               North America, LLC
830   RETIN-A            Cream            0.05%                Valeant Pharmaceuticals   02/06/2014
                                                               North America, LLC
831   RETIN-A            Cream            0.1 %                Valeant Pharmaceuticals   01/26/1973
                                                               North America, LLC
832   RETIN-A            Cream            0.025%               Valeant Pharmaceuticals   09/2014 - 09/2015
                                                               North America, LLC
833   RETIN-A            Cream            0.025%               Valeant Pharmaceuticals   09/2014 - 09/2015
                                                               North America, LLC
834   RETIN-A            Cream            0.05%                Valeant Pharmaceuticals   06/2005
                                                               North America, LLC
                                                               Valeant Pharmaceuticals
                                                               North America, LLC
                                                               Valeant Pharmaceuticals
                                                               North America, LLC
                                                                                            Date Authorized
      Proprietary Name    Dosage Form              Strength    NDA Applicant Name               Generic
                                                                                          Entered the Market
835   RETIN-A            Gel             0.025%               Valeant Pharmaceuticals   02/06/2014
                                                              North America, LLC
836   RETIN-A            Gel             0.01 %               Valeant Pharmaceuticals   02/06/2014
                                                              North America, LLC
837   RETIN-A            Gel             0.025%               Valeant Pharmaceuticals   06/2005
                                                              North America, LLC
838   RETIN-A MICRO      Gel             0.04%                Valeant Pharmaceuticals   03/2013
                                                              North America, LLC
839   RETIN-A MICRO      Gel             0.04%                Valeant Pharmaceuticals   10/01/2014
                                                              North America, LLC
840   RETIN-A MICRO      Gel             0.1%                 Valeant Pharmaceuticals   10/01/2014
                                                              North America, LLC
841   RETIN-A MICRO      Gel             0.1 %                Valeant Pharmaceuticals   03/2013
                                                              North America, LLC
842   RETIN-A MICRO      Gel             0.08%                Valeant Pharmaceuticals   03/2013
                                                              North America, LLC
843   REVATIO            Tablets         20 mg                Pfizer                    11/6/2012
844   RILUTEK            Tablets         50 mg                Covis Pharma B.V.         05/15/2013
845   RISPERDAL          Oral Solution   1 mg/mL              Janssen Research &        06/30/2008
                                                              Development, LLC
846   RISPERDAL          Tablets         0.25 mg              Janssen Research &        06/30/2008
                                                              Development, LLC
847   RISPERDAL          Tablets         0.5 mg               Janssen Research &        06/30/2008
                                                              Development, LLC
848   RISPERDAL          Tablets         1 mg                 Janssen Research &        06/30/2008
                                                              Development, LLC
                                                                                          Date Authorized
      Proprietary Name    Dosage Form              Strength    NDA Applicant Name             Generic
                                                                                        Entered the Market
849   RISPERDAL          Tablets          2 mg                Janssen Research &      06/30/2008
                                                              Development, LLC
850   RISPERDAL          Tablets          3 mg                Janssen Research &      06/30/2008
                                                              Development, LLC
851   RISPERDAL          Tablets          4 mg                Janssen Research &      06/30/2008
                                                              Development, LLC
852   RISPERDAL M-TAB    Orally           0.5 mg              Janssen Research &      06/30/2008
                         Disintegrating                       Development, LLC
                         Tablets
853   RISPERDAL M-TAB    Orally           1 mg                Janssen Research &      02/24/2009
                         Disintegrating                       Development, LLC
                         Tablets
854   RISPERDAL M-TAB    Orally           2 mg                Janssen Research &      02/24/2009
                         Disintegrating                       Development, LLC
                         Tablets
855   RISPERDAL M-TAB    Orally           3 mg                Janssen Research &      02/24/2009
                         Disintegrating                       Development, LLC
                         Tablets
856   RISPERDAL M-TAB    Orally           4 mg                Janssen Research &      02/24/2009
                         Disintegrating                       Development, LLC
                         Tablets
857   RITALIN            Tablet           20 mg               Novartis Pharamceuticals 8/23/2007
                                                              Corp
858   RITALIN            Tablet           5 mg                Novartis Pharmaceuticals 10/09/2007
                                                              Corp
859   RITALIN            Tablet           10 mg               Novartis Pharmaceuticals 6/8/2007
                                                              Corp
                                                                                                   Date Authorized
      Proprietary Name     Dosage Form                  Strength       NDA Applicant Name              Generic
                                                                                                 Entered the Market
860   RITALIN SR          Extended-         20 mg                     Novartis Pharmaceuticals 03/09/2007
                          release Tablets                             Corporation
861   ROBINUL             Injection         0.2 mg/mL                 Eurohealth International 02/06/1975
                                                                      Sarl
862   ROBINUL             Tablets           1 mg                      Shionogi Pharma, Inc.    01/13/2005
863   ROBINUL FORTE       Tablets           2 mg                      Shionogi Pharma, Inc.    01/13/2005
864   ROCALTROL           Capsules          0.25 mcg                  Validus Pharmaceuticals 08/26/2009
                                                                      LLC
865   ROCALTROL           Capsules          0.5 mcg                   Validus Pharmaceuticals 08/26/2009
                                                                      LLC
866   ROCALTROL           Oral Solution     1 mcg/mL (15 mL bottle)   Validus Pharmaceuticals 08/26/2009
                                                                      LLC
867   ROGAINE (FOR MEN)   Topical           2%                        McNeil-PPC, Inc.         06/1998 - 05/1999
                          Solution
868   ROGAINE (FOR        Topical           2%                        McNeil-PPC, Inc.        06/1998 - 05/1999
      WOMEN)              Solution
869   ROGAINE EXTRA       Topical           5%                        McNeil-PPC, Inc.        2004
      STRENGTH (FOR       Solution
      MEN)
870   ROWASA              Rectal Enema      4 gm/60 mL                Meda Pharmaceuticals     2009
                                                                      Inc.
871   ROWASA              Rectal Enema      4 gm/60 mL                Meda Pharmaceutical Inc. 2/2011
872   RYTHMOL SR          Extended-         325 mg                    GlaxoSmithKline LLC      10/22/2014
                          release
                          Capsules
                                                                                                    Date Authorized
      Proprietary Name    Dosage Form             Strength             NDA Applicant Name               Generic
                                                                                                   Entered the Market
873   RYTHMOL SR         Extended-      425 mg                        GlaxoSmithKline LLC        Unknown
                         release
                         Capsules
874   RYTHMOL SR         Extended-      225 mg                        GlaxoSmithKline LLC        10/22/2013
                         release
                         Capsules
875   SALAGEN            Tablets        5 mg                          MGI Pharma, Inc.           12/2004
876   SALAGEN            Tablets        7.5 mg                        MGI Pharma, Inc.           03/2006 - 01/2007
877   SANDOSTATIN        Injection      eq. 0.05 mg base/mL           Novartis Pharmaceuticals   04/13/2005
                                                                      Corporation
878   SANDOSTATIN        Injection      eq. 0.1 mg base/mL            Novartis Pharmaceuticals   04/13/2005
                                                                      Corporation
879   SANDOSTATIN        Injection      eq. 0.2 mg base/mL            Novartis Pharmaceuticals   04/13/2005
                                                                      Corporation
880   SANDOSTATIN        Injection      eq. 0.5 mg base/mL            Novartis Pharmaceuticals   04/13/2005
                                                                      Corporation
881   SANDOSTATIN        Injection      eq. 1 mg base/mL              Novartis Pharmaceuticals   04/13/2005
                                                                      Corporation
882   SEASONALE          Tablets        0.15 mg; 0.03 mg              Duramed Pharmaceuticals,   9/7/2006
                                                                      Inc.
883   SEASONIQUE         Tablets        0.15 mg/0.03 mg and 0.01 mg   Teva Branded               07/28/2010
                                                                      Pharmaceutical Products
884   SECTRAL            Capsules       eq. 200 mg base               Wyeth Laboratories, Inc.   Prior to 1/1/1999
885   SECTRAL            Capsules       eq. 400 mg base               Wyeth Laboratories, Inc.   Prior to 1/1/1999
886   SEPTOCAINE         Injection      4% and 1:200,000              Deproco, Inc.              01/2015
887   SEPTOCAINE         Injection      4% and 1:100,000              Deproco, Inc.              01/2015
                                                                                                          Date Authorized
      Proprietary Name    Dosage Form               Strength               NDA Applicant Name                   Generic
                                                                                                        Entered the Market
888   SILVADENE          Cream           1%                               King Pharmaceuticals,       Prior to 1/1/1999
                                                                          Inc.
889   SINGULAIR          Oral Granules   4 mg                             Merck Sharp & Dohme         8/7/2013
                                                                          Corp
890   SKELAXIN           Tablets         800 mg                           King Pharmaceuticals        04/01/2010
                                                                          R&D, LLC
891   SODIUM EDECRIN     Powder, for     50 mg/vial (single dose vial for Aton Pharma, Inc.           01/2015 - 01/2016
                         Solution        preparation of IV solution)
892   SOLARAZE           Gel             3%                               Fougera Pharmaceuticals,    11/21/2013
                                                                          Inc.
893   SOMA               Tablet          250 mg                           Meda Pharmaceuticals        9/13/2010
894   SORIATANE          Capsules        25 mg                            Stiefel Laboratories Inc.   7/22/2013
895   SORIATANE          Capsules        10 mg                            Stiefel Laboratories Inc.   7/22/2013
896   SPECTRACEF         Tablets         400 mg                           Vansen Pharma, Inc.         Unknown
897   SPECTRACEF         Tablets         200 mg                           Vansen Pharma, Inc.         Unknown
898   SPORANOX           Capsule         100 mg                           Janssen Research &          2/2005; 6/2005
                                                                          Development, LLC
899   STALEVO 100        Film-coated     25 mg, 100 mg, 200 mg            Orion Pharma                06/2014
                         Tablets
900   STALEVO 100        Film-coated     25 mg, 100 mg, 200 mg           Orion Pharma                 10/2012
                         Tablets
901   STALEVO 125        Film-coated     31.25 mg, 125 mg, 200 mg        Orion Pharma                 4/2012
                         Tablets
902   STALEVO 125        Film-coated     31.25 mg, 125 mg, 200 mg        Orion Pharma                 06/2014
                         Tablets
                                                                                             Date Authorized
      Proprietary Name    Dosage Form             Strength          NDA Applicant Name           Generic
                                                                                           Entered the Market
903   STALEVO 150        Film-coated    37.5 mg, 150 mg, 200 mg    Orion Pharma          10/2012
                         Tablets
904   STALEVO 150        Film-coated    37.5mg, 150 mg, 200 mg     Orion Pharma          06/2014
                         Tablets
905   STALEVO 200        Film-coated    50 mg, 200 mg, 200 mg      Orion Pharma          06/2014
                         Tablets
906   STALEVO 200        Film-coated    50 mg, 200 mg, 200 mg      Orion Pharma          4/2012
                         Tablets
907   STALEVO 50         Film-coated    12.5 mg, 50 mg, 200 mg     Orion Pharma          06/2014
                         Tablets
908   STALEVO 50         Film-coated    12.5 mg, 50 mg, 200 mg     Orion Pharma          4/2012
                         Tablets
909   STALEVO 75         Film-coated    18.75 mg, 75 mg, 200 mg    Orion Pharma          06/2014
                         Tablets
910   STALEVO 75         Film-coated    18.75 mg, 75 mg, 200 mg    Orion Pharma          4/2012
                         Tablets
911   STALEVO 75         Film-coated    18.75 mg, 75 mg, 200 mg    Orion Pharma          10/2013
                         Tablets
912   STELEVO 100        Film-coated    25 mg, 100 mg, 200 mg      Orion Pharma          10/2013
                         Tablets
913   STELEVO 125        Film-coated    31.25 mg, 125 mg, 200 mg   Orion Pharma          10/2013
                         Tablets
914   STELEVO 150        Film-coated    37.5 mg, 150 mg, 200 mg    Orion Pharma          10/2013
                         Tablets
915   STELEVO 200        Film-coated    50 mg, 200 mg, 200 mg      Orion Pharma          10/2013
                         Tablets
                                                                                              Date Authorized
      Proprietary Name    Dosage Form               Strength       NDA Applicant Name              Generic
                                                                                            Entered the Market
916   STRATTERA          Capsules          100 mg                 Eli Lilly and Company   05/2017
917   STRATTERA          Capsules          60 mg                  Eli Lilly and Company   05/2017
918   STRATTERA          Capsules          40 mg                  Eli Lilly and Company   05/2017
919   STRATTERA          Capsules          25 mg                  Eli Lilly and Company   05/2017
920   STRATTERA          Capsules          18 mg                  Eli Lilly and Company   05/2017
921   STRATTERA          Capsules          10 mg                  Eli Lilly and Company   05/2017
922   STRATTERA          Capsules          80 mg                  Eli Lilly and Company   05/2017
923   SULAR              Extended-         17 mg                  Covis Pharma B.V.       2/2012 - 2/2013
                         release Tablets
924   SULAR              Extended-         34 mg                  Covis Pharma B.V.       2/2012 - 2/2013
                         release Tablets
925   SULAR              Extended-         8.5 mg                 Covis Pharma B.V.       2/2012 - 2/2013
                         release Tablets
926   SYNALAR            Cream             0.01%                  Medimetriks             Unknown
                                                                  Pharmaceuticals, Inc.
927   SYNALAR            Cream             0.025%                 Medimetriks             12/2012
                                                                  Pharmaceuticals, Inc.
928   SYNALAR            Ointment          0.025%                 Medimetriks             12/2012
                                                                  Pharmaceuticals, Inc.
929   SYNALAR            Solution          0.01%                  Medimetriks             11/2012
                                                                  Pharmaceuticals, Inc.
930   SYNALGOS-DC        Capsules          356.4 mg/30 mg/16 mg   Sun Pharmaceutical      10/01/2012
                                                                  Industries, Inc.
931   TACLONEX           Ointment          0.005%/0.064%          LEO Pharma A/S          04/2014
932   TAMBOCOR           Tablets           50 mg                  3M Pharmaceuticals      10/2002
                                                                                                     Date Authorized
      Proprietary Name    Dosage Form                 Strength          NDA Applicant Name               Generic
                                                                                                   Entered the Market
933   TAMBOCOR           Tablets           100 mg                      3M Pharmaceuticals        10/2002
934   TAMBOCOR           Tablets           150 mg                      3M Pharmaceuticals        10/2002
935   TARGRETIN          Capsules          75 mg                       Valeant Pharmaceuticals   12/2015
                                                                       North America, LLC
936   TARKA              Extended-         4 mg Trandolapril, 240 mg   AbbVie                    02/25/2015
                         release Tablets   Verapamil Hydrochloride
937   TARKA              Extended-         2 mg Trandolapril, 180 mg   AbbVie                    02/25/2015
                         release Tablets   Verapamil Hydrochloride
938   TARKA              Extended-         2 mg Trandolapril, 240 mg   AbbVie                    02/25/2015
                         release Tablets   Verapamil Hydrochloride
939   TARKA              Extended-         1 mg Trandolapril, 240 mg   AbbVie                    02/25/2015
                         release Tablets   Verapamil Hydrochloride
940   TASMAR             Tablets           100 mg                      Valeant Pharmaceuticals   07/2004
                                                                       North America, LLC
941   TAXOTERE           Injection         80 mg/4 mL                  Sanofi Aventis US LLC     03/2011
                         Concentrate
942   TAXOTERE           Injection         20 mg/mL                    Sanofi Aventis US LLC     03/2011
                         Concentrate
943   TAZORAC            Cream             0.05%                       Allergan                  10/2016
944   TAZORAC and        Cream             0.1%                        Allergan                  10/2016
      AVAGE
945   TEGRETOL XR        Tablets           100 mg                      Novartis Pharmaceuticals 03/2016
                                                                       Corporation
946   TEGRETOL XR        Tablets           200 mg                      Novartis Pharmaceuticals 06/15/2009
                                                                       Corporation
                                                                                              Date Authorized
      Proprietary Name    Dosage Form                Strength    NDA Applicant Name                 Generic
                                                                                            Entered the Market
947   TEGRETOL XR        Tablets           400 mg               Novartis Pharmaceuticals 06/15/2009
                                                                Corporation
948   TEMODAR            Capsules          20 mg                Merck Sharp & Dohme       8/12/2013
                                                                Corporation
949   TEMODAR            Capsules          5 mg                 Merck Sharp & Dohme       8/12/2013
                                                                Corporation
950   TEMODAR            Capsules          100 mg               Merck Sharp & Dohme       8/12/2013
                                                                Corporation
951   TEMODAR            Capsules          140 mg               Merck Sharp & Dohme       8/12/2013
                                                                Corporation
952   TEMODAR            Capsules          180 mg               Merck Sharp & Dohme       8/12/2013
                                                                Corporation
953   TEMODAR            Capsules          250 mg               Merck Sharp & Dohme       8/12/2013
                                                                Corporation
954   TENUATE            Immediate-        25 mg                Actavis Laboratories UT 12/20/1996
                         release Tablets                        Inc.
955   TENUATE DOSPAN     Controlled-       75 mg                Actavis Laboratories UT, 07/24/1994
                         release Tablets                        Inc.
956   TESSALON           Capsules          100 mg               Forest Laboratories, Inc. Prior to 1/1/1999
957   TESSALON           Capsules          200 mg               Forest Laboratories, Inc. 04/1999 - 04/2000
958   TESTIM             Gel               50 mg in 5 g         Auxilium                  06/09/2014
                                                                Pharmaceuticals, Inc.
959   TIAZAC             Extended-         240 mg               Valeant Pharmaceuticals 08/20/2014
                         release                                North America, LLC
                         Capsules
                                                                                             Date Authorized
      Proprietary Name    Dosage Form            Strength    NDA Applicant Name                  Generic
                                                                                           Entered the Market
960   TIAZAC             Extended-      120 mg              Valeant Pharmaceuticals      08/20/2014
                         release                            North America, LLC
                         Capsules
961   TIAZAC             Extended-      180 mg              Valeant Pharmaceuticals      08/20/2014
                         release                            North America, LLC
                         Capsules
962   TIAZAC             Extended-      300 mg              Valeant Pharmaceuticals      08/20/2014
                         release                            North America, LLC
                         Capsules
963   TIAZAC             Extended-      360 mg              Valeant Pharmaceuticals      08/20/2014
                         release                            North America, LLC
                         Capsules
964   TIAZAC             Extended-      420 mg              Valeant Pharmaceuticals      08/20/2014
                         release                            North America, LLC
                         Capsules
965   TIGAN              Injection      100 mg/mL           Par Sterile Products, LLC    06/01/2012
966   TIKOSYN            Capsules       0.5 mg              Pfizer                       05/01/2016
967   TIKOSYN            Capsules       0.25 mg             Pfizer                       05/01/2016
968   TIKOSYN            Capsules       0.125 mg            Pfizer                       05/01/2016
969   TIMOPTIC-XE        Solution       0.5%                Aton Pharma, a division of   11/1993
                                                            VPNA LLC
970   TINDAMAX           Tablets        250 mg              Mission Pharmacal            06/07/2012
                                                            Company
971   TINDAMAX           Tablets        500 mg              Mission Pharmacal            06/07/2012
                                                            Company
                                                                                             Date Authorized
      Proprietary Name    Dosage Form               Strength     NDA Applicant Name                Generic
                                                                                           Entered the Market
972   TOBI               Solution for      300 mg/5 mL ampule   Novartis Pharmaceuticals 07/2014
                         Inhalation                             Corporation
973   TOBRADEX           Opthalmic         0.3%, 0.1%           Novartis Pharmaceuticals 01/02/2009
                         Suspension                             Corporation
974   TOFRONIL PM        Capsules          75 mg                Mallinckrodt Inc.        4/2006
975   TOFRONIL PM        Capsules          125 mg               Mallinckrodt Inc.        4/2006
976   TOFRONIL PM        Capsules          150 mg               Mallinckrodt Inc.        4/2006
977   TOFRONIL PM        Capsules          100 mg               Mallinckrodt Inc.        4/2006
978   TOPROL XL          Extended-         100 mg               Aralez Pharmaceuticals   01/2018
                         release Tablets                        Trading DAC
979   TOPROL XL          Extended-         25 mg                Aralez Pharmaceuticals   01/2018
                         release Tablets                        Trading DAC
980   TOPROL XL          Extended-         50 mg                Aralez Pharmaceuticals   01/2018
                         release Tablets                        Trading DAC
981   TOPROL XL          Extended-         200 mg               Aralez Pharmaceuticals   01/2018
                         release Tablets                        Trading DAC
982   TORADOL            Tablets           10 mg                Syntex (U.S.A.) Inc.     Prior to 1/1/1999
983   TRANDATE           Tablets           200 mg               County Line              12/01/2014
                                                                Pharmaceuticals, LLC
984   TRANDATE           Tablets           300 mg               County Line              12/01/2014
                                                                Pharmaceuticals, LLC
985   TRANDATE           Tablets           100 mg               County Line              12/01/2014
                                                                Pharmaceuticals, LLC
986   TRICOR             Tablets           145 mg               AbbVie Inc.              04/2014
987   TRICOR             Tablets           48 mg                AbbVie Inc.              04/2014
                                                                                                       Date Authorized
       Proprietary Name    Dosage Form                Strength              NDA Applicant Name             Generic
                                                                                                     Entered the Market
988   TRILEPTAL           Oral              300 mg/5 mL                   Novartis Pharmaceuticals 01/04/2011
                          Suspension                                      Corporation
989   TRILIPIX            Delayed Release   135 mg                        AbbVie Inc.              07/15/2013
                          Capsules
990   TRILIPIX            Delayed Release   45 mg                         AbbVie Inc.                07/15/2013
                          Capsules
991   TRILIPIX            Delayed Release   45 mg                         AbbVie Inc.                07/15/2013
                          Capsules
992   TRILIPIX            Delayed Release   135 mg                        AbbVie Inc.                07/15/2013
                          Capsules
993   TRI-NORINYL         Tablets           0.5 mg, 1 mg, 0.5 mg; 0.035    Mayne Pharma LLC          1/12/2005
                                            mg, 0.035 mg, 0.035 mg
994   TUSSIONEX           Extended-         10 mg hydrocodone bitartrate & UCB, Inc.                 10/2010
                          Release           8 mg chlorpheniramine maleate
                          Suspension        per 5 mL
995   ULTRAM              Extended-         100 mg                         Valeant Pharmaceuticals   01/16/2006
                          release Tablets                                  North America LLC
996   ULTRAM              Extended-         300 mg                         Valeant Pharmaceuticals   01/16/2006
                          release Tablets                                  North America LLC
997   ULTRAM              Extended-         200 mg                         Valeant Pharmaceuticals   01/16/2006
                          release Tablets                                  North America LLC
998   ULTRAVATE           Cream             0.05%                          Bristol-Myers Squibb      11/2004 - 10/2005
                                                                           Company
999   ULTRAVATE           Ointment          0.05%                          Bristol-Myers Squibb      11/2004 - 10/2005
                                                                           Company
                                                                                                    Date Authorized
     Proprietary Name    Dosage Form                 Strength            NDA Applicant Name             Generic
                                                                                                  Entered the Market
1000 UNITHROID          Tablets           0.025 mg                      Jerome Stevens          08/2002 - 07/2003
                                                                        Pharmaceuticals, Inc.
1001 UNITHROID          Tablets           0.05 mg                       Jerome Stevens          08/2002 - 07/2003
                                                                        Pharmaceuticals, Inc.
1002 UNITHROID          Tablets           0.075 mg                      Jerome Stevens          08/2002 - 07/2003
                                                                        Pharmaceuticals, Inc.
1003 UNITHROID          Tablets           0.088 mg                      Jerome Stevens          08/2002 - 07/2003
                                                                        Pharmaceuticals, Inc.
1004 UNITHROID          Tablets           0.1 mg                        Jerome Stevens          08/2002 - 07/2003
                                                                        Pharmaceuticals, Inc.
1005 UNITHROID          Tablets           0.112 mg                      Jerome Stevens          08/2002 - 07/2003
                                                                        Pharmaceuticals, Inc.
1006 UNITHROID          Tablets           0.125 mg                      Jerome Stevens          08/2002 - 07/2003
                                                                        Pharmaceuticals, Inc.
1007 UNITHROID          Tablets           0.15 mg                       Jerome Stevens          08/2002 - 07/2003
                                                                        Pharmaceuticals, Inc.
1008 UNITHROID          Tablets           0.175 mg                      Jerome Stevens          08/2002 - 07/2003
                                                                        Pharmaceuticals, Inc.
1009 UNITHROID          Tablets           0.2 mg                        Jerome Stevens          08/2002 - 07/2003
                                                                        Pharmaceuticals, Inc.
1010 UNITHROID          Tablets           0.3 mg                        Jerome Stevens          08/2002 - 07/2003
                                                                        Pharmaceuticals, Inc.
1011 UREX               Tablets           1 gram                        County Line             Unknown
                                                                        Pharmaceuticals, LLC
1012 UROCIT-K           Extended-         15 mEQ (1620 mg) per tablet   Mission Pharmacal       12/23/2013
                        release Tablets
                                                                                                         Date Authorized
       Proprietary Name    Dosage Form                Strength             NDA Applicant Name                Generic
                                                                                                       Entered the Market
1013 UROCIT-K             Extended-         540 mg (5 mEq per tablet)     Mission Pharmacal          11/2007
                          release Tablets
1014 UROCIT-K             Extended-         1080 mg (10 mEq per tablet)   Mission Pharmacal          11/2007
                          release Tablets
1015   URSO 250           Tablets           250 mg                        Allergan Sales, LLC        07/06/2009
1016   URSO FORTE         Tablets           500 mg                        Allergan Sales, LLC        07/06/2009
1017   VAGIFEM            Vaginal Inserts   10 mcg                        Novo Nordisk, Inc.         01/2018
1018   VAGISTAT-1         Vaginal           6.50%                         Bristol-Myers Squibb       02/1998 - 02/1999
                          Ointment                                        Company
1019 VANCOCIN             Capsules          250 mg                        ANI Pharmaceuticals Inc.   10/26/2015
1020 VANCOCIN             Capsules          125 mg                        ANI Pharmaceuticals Inc.   10/26/2015
1021 VANOS                Cream             0.1%                          Medicis Pharmaceutical     01/2014
                                                                          Corp., Division of VPNA
1022 VASERETIC            Tablets           10 mg/25 mg                   Valeant Pharmaceuticals    10/31/1986
                                                                          North America, LLC
1023 VASOTEC              Tablets           20 mg                         Valeant Pharmaceuticals    12/24/1985
                                                                          North America, LLC
1024 VASOTEC              Tablets           2.5 mg                        Valeant Pharmaceuticals    07/26/1988
                                                                          North America, LLC
1025 VASOTEC              Tablets           5 mg                          Valeant Pharmaceuticals    12/24/1985
                                                                          North America, LLC
1026 VASOTEC              Tablets           10 mg                         Valeant Pharmaceuticals    12/24/1985
                                                                          North America, LLC
1027 VECTICAL             Ointment          3 mcg/g                       Galderma Laboratories,     02/28/2012
                                                                          L.P.
                                                                                        Date Authorized
     Proprietary Name    Dosage Form             Strength    NDA Applicant Name             Generic
                                                                                      Entered the Market
1028 VENLAFAXINE        Tablet,        75 mg                Osmotica Pharmaceutical 04/2010
    HYDROCHLORIDE       Extended                            US LLC
    EXTENDED RELEASE
    TABLETS
                        Release
1029 VENLAFAXINE        Tablet,        225 mg               Osmotica Pharmaceutical 04/2010
    HYDROCHLORIDE       Extended                            US LLC
    EXTENDED RELEASE
    TABLETS
                        Release
1030 VENLAFAXINE        Tablet,        37.5 mg              Osmotica Pharmaceutical 04/2010
    HYDROCHLORIDE       Extended                            US LLC
    EXTENDED RELEASE
    TABLETS
                        Release
1031 VENLAFAXINE        Tablet,        150 mg               Osmotica Pharmaceutical 04/2010
    HYDROCHLORIDE       Extended                            US LLC
    EXTENDED RELEASE
    TABLETS
                        Release
1032 VENLAFAXINE        Tablet,        37.5 mg              Osmotica Pharmaceutical 04/2010
    HYDROCHLORIDE       Extended                            US LLC
    EXTENDED RELEASE
    TABLETS
                        Release
1033 VENLAFAXINE        Tablet,        75 mg                Osmotica Pharmaceutical 04/2010
    HYDROCHLORIDE       Extended                            US LLC
    EXTENDED RELEASE
    TABLETS
                        Release
1034 VENLAFAXINE        Tablet,        150 mg               Osmotica Pharmaceutical 04/2010
    HYDROCHLORIDE       Extended                            US LLC
    EXTENDED RELEASE
    TABLETS
                        Release
1035 VENLAFAXINE        Tablet,        225 mg               Osmotica Pharmaceutical 04/2010
    HYDROCHLORIDE       Extended                            US LLC
    EXTENDED RELEASE
    TABLETS
                        Release
                                                                                               Date Authorized
     Proprietary Name    Dosage Form                Strength      NDA Applicant Name               Generic
                                                                                             Entered the Market
1036 VENOFER            Injection         2% w/v iron (Fe)       Luitpold Pharmaceuticals, 10/02/08
                                                                 Inc.
1037 VERELAN            Sustained-        120 mg                 Recro Gainesville LLC     5/17/1999
                        release
                        Capsules
1038 VERELAN            Sustained-        180 mg                 Recro Gainesville LLC   5/17/1999
                        release
                        Capsules
1039 VERELAN            Sustained-        240 mg                 Recro Gainesville LLC   5/17/1999
                        release
                        Capsules
1040 VERELAN            Sustained-        360 mg                 Recro Gainesville LLC   5/17/1999
                        release
                        Capsules
1041 VERELAN PM         Extended-         100 mg                 Recro Gainesville LLC   11/2006 - 11/2007
                        release
                        Capsules
1042 VERELAN PM         Extended-         200 mg                 Recro Gainesville LLC   11/2006 - 11/2007
                        release
                        Capsules
1043 VERELAN PM         Extended-         300 mg                 Recro Gainesville LLC   11/2006 - 11/2007
                        release
                        Capsules
1044 VFEND              Powder for Oral   40 mg/mL (75 mL when   PF Prism C.V.           12/16/2013
                        Suspension        reconstituted)
1045 VFEND              Tablets           200 mg                 PF Prism C.V.           07/08/2010
1046 VFEND              Tablets           50 mg                  PF Prism C.V.           07/08/2010
                                                                                                   Date Authorized
     Proprietary Name    Dosage Form                   Strength      NDA Applicant Name                Generic
                                                                                                 Entered the Market
1047 VIDAZA             Injection,         100 mg single-use vial   Celgene Corporation        09/16/2013
                        Powder,
                        Lyophylized, for
                        Solution
1048 VIGAMOX            Ophthalmic         0.5%                     Novartis Pharmaceuticals   01/2017
                        Solution                                    Corporation
1049 VIRAMUNE           Oral               50 mg/5 mL               Boehringer-Ingleheim       05/21/2012
                        Suspension                                  Pharmaceuticals, Inc.
1050 VIRAMUNE           Tablets            200 mg                   Boehringer-Ingleheim       05/21/2012
                                                                    Pharmaceuticals, Inc.
1051 VIVELLE-DOT        Transdermal        0.1 mg                   Novartis Pharmaceuticals   12/2014
                        System                                      Corporation
1052 VIVELLE-DOT        Transdermal        0.0375 mg                Novartis Pharmaceuticals   12/2014
                        System                                      Corporation
1053 VIVELLE-DOT        Transdermal        0.025 mg                 Novartis Pharmaceuticals   12/2014
                        System                                      Corporation
1054 VIVELLE-DOT        Transdermal        0.05 mg                  Novartis Pharmaceuticals   12/2014
                        System                                      Corporation
1055 VIVELLE-DOT        Transdermal        0.075 mg                 Novartis Pharmaceuticals   12/2014
                        System                                      Corporation
1056 VOGELXO            Gel                50 mg                    Upsher-Smith               06/2014
                                                                    Laboratories
1057 VOLTAREN           Delayed-release 25 mg                       Novartis Pharmaceuticals   Prior to 1/1/1999
                        Tablets                                     Corporation
1058 VOLTAREN           Delayed-release 50 mg                       Novartis Pharmaceuticals   Prior to 1/1/1999
                        Tablets                                     Corporation
                                                                                                   Date Authorized
     Proprietary Name    Dosage Form                Strength         NDA Applicant Name                Generic
                                                                                                 Entered the Market
1059 VOLTAREN           Gel               1%                        GlaxoSmithKline            07/2016
                                                                    Consumer Healthcare
1060 VOLTAREN XR        Extended-         100 mg                    Novartis Pharmaceuticals   05/22/2000
                        release Tablets                             Corporation
1061 XALATAN            Ophthalmic        0.005% (125 mcg/2.5 mL)   Pharmacia and Upjohn       11/15/2010
                        Solution                                    Company
1062 XANAX              Tablets           0.25 mg                   Pharmacia and Upjohn       06/17/2003
                                                                    Company
1063 XANAX              Tablets           0.5 mg                    Pharmacia and Upjohn       06/18/2003
                                                                    Company
1064 XANAX              Tablets           1 mg                      Pharmacia and Upjohn       06/18/2003
                                                                    Company
1065 XANAX              Tablets           2 mg                      Pharmacia and Upjohn       06/18/2003
                                                                    Company
1066 XANAX XR           Extended-         0.5 mg                    Pharmacia and Upjohn       11/16/2005
                        release Tablets
1067 XANAX XR           Extended-         1 mg                      Pharmacia and Upjohn       11/16/2005
                        release Tablets
1068 XANAX XR           Extended-         2 mg                      Pharmacia and Upjohn       11/16/2005
                        release Tablets
1069 XANAX XR           Extended-         3 mg                      Pharmacia and Upjohn       11/16/2005
                        release Tablets
1070 XENAZINE           Tablets           25 mg                     Valeant Pharmaceuticals    07/20/2015
                                                                    North America, LLC
1071 XENAZINE           Tablets           12.5 mg                   Valeant Pharmaceuticals    07/20/2015
                                                                    North America, LLC
                                                                                                Date Authorized
       Proprietary Name    Dosage Form               Strength      NDA Applicant Name               Generic
                                                                                              Entered the Market
1072 XOPENEX              Inhalation      1.25 mg/3 mL            Oak Pharmaceuticals, Inc. 08/2012
                          Solution
1073 XOPENEX              Inhalation      0.31 mg/3 mL            Oak Pharmaceuticals, Inc. 08/2012
                          Solution
1074 XOPENEX              Inhalation      0.63 mg/3 mL            Oak Pharmaceuticals, Inc. 08/2012
                          Solution
1075 YASMIN               Tablets         3 mg; 0.03 mg           Bayer HealthCare          05/09/2008
                                                                  Pharmaceuticals Inc.
1076 ZARONTIN             Capsules        250 mg                  Parke-Davis Division of   10/12/2015
                                                                  Pfizer Inc.
1077 ZARONTIN             Oral Solution   250 mg/5 mL             Parke-Davis Division of   10/12/2015
                                                                  Pfizer Inc.
1078   ZAROXOLYN          Tablets         2.5 mg                  UCB, Inc.                 11/2002 - 10/2003
1079   ZAROXOLYN          Tablets         5 mg                    UCB, Inc.                 11/2002 - 10/2003
1080   ZAROXOLYN          Tablets         10 mg                   UCB, Inc.                 11/2002 - 10/2003
1081   ZEBETA             Tablets         5 mg                    Lederle Laboratories      08/2000 - 08/2001
1082   ZEBETA             Tablets         10 mg                   Lederle Laboratories      08/2000 - 08/2001
1083   ZEGERID            Capsules        40 mg                   Salix Pharmaceuticals,    02/27/2006
                                                                  Inc.
1084 ZEGERID              Capsules        20 mg                   Salix Pharmaceuticals,    02/27/2006
                                                                  Inc.
1085 ZEMPLAR              Capsules        2 mcg                   AbbVie Inc.               03/2014
1086 ZEMPLAR              Capsules        1 mcg                   AbbVie Inc.               03/2014
1087 ZENPEP               Delayed Release 5000 lipase USP units   Eurand Pharmaceuticals,   12/2/2009
                          Capsules                                Ltd.
                                                                                                        Date Authorized
       Proprietary Name    Dosage Form                 Strength            NDA Applicant Name               Generic
                                                                                                      Entered the Market
1088   ZIAC               Tablets           2.5 mg; 6.25 mg               Lederle Laboratories      07/2000 - 07/2001
1089   ZIAC               Tablets           5 mg; 6.25 mg                 Lederle Laboratories      07/2000 - 07/2001
1090   ZIAC               Tablets           10 mg; 6.25 mg                Lederle Laboratories      07/2000 - 07/2001
1091   ZITHROMAX          Powder for Oral   300 mg (15 mL when mixed)     Pfizer Inc.               02/01/2005
                          Suspension
1092 ZITHROMAX            Powder for Oral   600 mg (15 mL when mixed)     Pfizer Inc.               02/1/2005
                          Suspension
1093 ZITHROMAX            Powder for Oral   900 mg (22.5 mL when mixed) Pfizer Inc.                 02/01/2005
                          Suspension
1094 ZITHROMAX            Powder for Oral   1 gram (single dose packet)   Pfizer Inc.               2/1/2005
                          Suspension
1095 ZITHROMAX            Powder for Oral   1200 mg (30 mL when mixed) Pfizer Inc.                  02/01/2005
                          Suspension
1096   ZITHROMAX          Tablets           250 mg                        Pfizer Inc.               02/01/2005
1097   ZITHROMAX          Tablets           500 mg                        Pfizer Inc.               02/01/2005
1098   ZITHROMAX          Tablets           600 mg                        Pfizer Inc.               2/1/2005
1099   ZOLOFT             Oral              20 mg/mL                      Pfizer Inc.               03/20/2006
                          Concentrate
1100   ZOLOFT             Tablets           25 mg                         Pfizer Inc.               03/20/2006
1101   ZOLOFT             Tablets           50 mg                         Pfizer Inc.               03/20/2006
1102   ZOLOFT             Tablets           100 mg                        Pfizer Inc.               03/20/2006
1103   ZONALON and        Cream             5%                            Mylan Pharmaceuticals,    03/2016
       PRUDOXIN                                                           Inc.
1104 ZOVIRAX              Ointment          5%                            Valeant Pharmaceuticals   04/2014
                                                                          North America LLC
                                                                                                   Date Authorized
     Proprietary Name    Dosage Form               Strength           NDA Applicant Name               Generic
                                                                                                 Entered the Market
1105 ZOVIRAX            Suspension        200 mg per 5 mL            Mylan Pharmaceuticals     09/2014
                                                                     Inc.
1106 ZUTRIPRO           Oral Solution     5 mg/4 mg/60 mg per 5 mL   Cypress Pharmaceutical,   01/2014
                                                                     Inc.
1107 ZYFLO              Extended-         600 mg                     Chiesi USA, Inc.          04/2017
                        release Tablets
1108 ZYVOX              Oral              100 mg/5 mL                Pharmacia and Upjohn      12/2015
                        Suspension                                   Company
1109 ZYVOX              Tablets           600 mg                     Pharmacia and Upjohn      12/2015
                                                                     Company
1110 ZYVOX              Tablets           600 mg                     Pharmacia and Upjohn      06/2015
                                                                     Company

